Podcasts about lewis katz school

  • 62PODCASTS
  • 92EPISODES
  • 32mAVG DURATION
  • 1MONTHLY NEW EPISODE
  • Mar 7, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about lewis katz school

Latest podcast episodes about lewis katz school

NHA Health Science Podcast
122: Healing Through Service: Dr. Meagan L. Grega's Journey from the Navy to Lifestyle Medicine

NHA Health Science Podcast

Play Episode Listen Later Mar 7, 2025 45:41


Episode Summary: In this episode of the Health Science Podcast, brought to you by the National Health Association, Dr. Frank Sabatino sits down with Dr. Meagan L. Grega, a board-certified physician in Family and Lifestyle Medicine and the Co-Founder and Chief Medical Officer of the Kellyn Foundation. Together, they discuss the power of community-driven health initiatives, the importance of making the healthy choice the easy choice, and how the Kellyn Foundation is working to transform neighborhoods with lifestyle medicine programs. Dr. Grega shares insights on the evolution of her career, from her early passion for service to her realization that true healing comes from prevention and community support. She explains how the Kellyn Foundation integrates school-based education, gardening programs, mobile markets, and hands-on cooking classes to create sustainable change in the Lehigh Valley. If you're looking to learn how lifestyle medicine can be a powerful force for improving health outcomes, this episode is a must-listen! About Our Guest: Meagan L. Grega, MD, FACLM, DipABLM, DipABFM Dr. Meagan L. Grega is a leader in Lifestyle Medicine and the Co-Founder and Chief Medical Officer of the Kellyn Foundation (www.kellyn.org), a non-profit dedicated to making the healthy choice the easy choice through community-based health initiatives. The foundation's “Healthy Neighborhood Immersion Strategy” integrates school-based wellness education, hands-on cooking classes, and a mobile market providing access to fresh, nutrient-dense food. Dr. Grega graduated summa cum laude from Bucknell University with a B.S. in Biochemistry/Cell Biology and earned her MD from the University of Pennsylvania Medical School. She served as a medical officer in the United States Navy and currently manages the Llantrisant Retreat and Wellness Center (www.llantrisantretreat.com). She is actively involved in medical education, serving as faculty for St. Luke's University Health Network and Temple University's Lewis Katz School of Medicine, and is the current Conference Chair for the American College of Lifestyle Medicine Annual Meeting. She also serves on the governing boards of both the American Board of Lifestyle Medicine and the American College of Lifestyle Medicine. Key Topics Discussed in This Episode: Dr. Grega's journey from aspiring shaman to board-certified physician How lifestyle medicine addresses the root causes of disease The role of social nudges and choice architecture in shaping healthy behaviors The Kellyn Foundation's programs, including school-based education, gardening initiatives, and the Eat Real Food Mobile Market Challenges in implementing lifestyle medicine in schools and how to overcome them The importance of medically tailored meals and expanding access to nutrition-focused healthcare How future physicians are being trained in lifestyle medicine Resources & Links: Kellyn Foundation: www.kellyn.org Llantrisant Retreat and Wellness Center: www.llantrisantretreat.com Connect with Us: Subscribe and leave a review on your favorite podcast platform! Read more at: https://www.healthscience.org/podcast/episode-122-meagan-grega/

The Skin Real
How to Stay Safe at Med Spas

The Skin Real

Play Episode Listen Later Mar 3, 2025 32:42


Get Dr. Mina's Ultimate (Affordable) Skincare Guide here. Get Dr. Mina's free PDF on How to create Healthy Skin Habits here. Join Dr. Mina and Dr. Mansha Sethi as they navigate the ever-evolving world of med spas. In this conversation, they break down popular aesthetic services, discuss industry regulations, and highlight why patient safety should always come first. From understanding the risks of non-physician providers to choosing a reputable med spa, this episode empowers listeners to make informed decisions about cosmetic treatments. Whether you're curious about injectables or considering your first med spa visit, this discussion sheds light on what every patient needs to know before booking an appointment. Key Takeaways: - Med spas offer a variety of non-invasive cosmetic procedures. - Regulation of med spas varies significantly by state. - Only a small percentage of med spas have proper physician oversight. - Complications can arise from aesthetic procedures, even in trained hands. - Patients should be cautious of overly cheap services. - It's essential to verify the qualifications of the providers at med spas. - Hydrafacials and laser hair removal are popular and effective treatments. - Patients should be wary of over-promising treatments and results. - Cleanliness and organization are critical indicators of a reputable med spa. - Collaboration between dermatologists and estheticians enhances patient care.   In This Episode: (02:00) Understanding Med Spas: A Comprehensive Overview (06:08) Regulation and Oversight of Med Spas (14:57) Complications and Patient Safety in Aesthetic Procedures (18:51) Choosing the Right Med Spa: Key Considerations (21:04) Best Practices and Treatments at Med Spas (25:23) Red Flags and Warning Signs at Med Spas (28:10) Final Thoughts: Ensuring Safety and Quality in Aesthetic Care   Dr. Mansha Sethi is a board-certified dermatologist serving both adult and pediatric patients. She currently practices medical, surgical, and cosmetic dermatology at St. Luke's University Health Network in PA. Part of her job includes training dermatology residents. Prior to this, Dr. Sethi worked at a private practice in Houston, TX. She grew up in Northeast Pennsylvania. She attended Cornell University in Ithaca, NY, for her Bachelor of Science, earning Dean's List each semester for academic record. She received her medical degree from the Lewis Katz School of Medicine at Temple University in Philadelphia. She was selected to present her research at local and national conferences – the Philadelphia Dermatological Society and the American Academy of Dermatology. She completed a year of internal medicine at Jefferson-Abington Hospital and her dermatology residency at Thomas Jefferson University. Philly holds a special place in her heart because she met her husband there. Dr. Sethi is a member of the American Academy of Dermatology (AAD) and the American Society of Dermatologic Surgery. She's one of the social media ambassadors for AAD. Outside work, she enjoys traveling, trying new restaurants, and spending time with family. She's navigating new mom life with her baby boy. Follow Dr. Sethi here: https://www.instagram.com/doctor_sethi   Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ For more great skin care tips, subscribe to The Skin Real Podcast or visit www.theskinreal.com Baucom & Mina Derm Surgery, LLC Email - scheduling@atlantadermsurgery.com Contact - (404) 844-0496 Instagram - https://www.instagram.com/baucomminamd/ Thanks for listening! The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice.

Finding Genius Podcast
Rethinking Schizophrenia Why Modern Treatments May Be Failing – And What We Can Do To Fix Them

Finding Genius Podcast

Play Episode Listen Later Feb 6, 2025 25:30


Why do individuals struggling with schizophrenia in the United States fare worse than patients in the world's poorest countries? Are modern treatments for the severely mentally ill effective? Joining us to dive into this salient topic is Robert Whitaker, a journalist and the author of four books: Mad in America, The Mapmaker's Wife, On the Laps of Gods, and Anatomy of an Epidemic.  Robert has won numerous awards as a journalist covering medicine and science, including the George Polk Award for Medical Writing and a National Association for Science Writers' Award for best magazine article. He is also the publisher of Madinamerica.com and a Clinical Assistant Professor (Adjunct) at Lewis Katz School of Medicine at Temple University's Department of Psychiatry and Behavioral Science. In this conversation, we cover:  Why long-term outcomes for schizophrenia patients have been worsening over time.  Potential reasons why developing countries have more success treating mental disorders.  Whether or not scientific literature on mental illness lines up with the narrative we've been told. What happens when dopamine receptors are overexpressed.  You can follow along with Robert and his important work here! Upgrade Your Wallet Game with Ekster!  Get the sleek, smart wallet you deserve—and save while you're at it! Use coupon code FINDINGGENIUS at checkout or shop now with this exclusive link: ekster.com?sca_ref=4822922.DtoeXHFUmQ5  Smarter, slimmer, better. Don't miss out! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

Bioethics in the Margins
Immigrant Health and the Work of Bioethics with Dr. Brian Tuohy

Bioethics in the Margins

Play Episode Listen Later Oct 30, 2024 41:54


We are back with season 7, chatting with Brian Tuohy, PhD, a sociologist of immigration and health, assistant professor of bioethics, and co-director of education at the Lewis Katz School of of Medicine at Temple University. We use the lens of immigrant health to delve into some deeper questions like "What does bioethics mean?" Dr. Tuohy generously shares his own personal and professional journey into the field, highlighting the interdisciplinary nature of bioethics. He discusses his own family's immigration story and research with Mexican immigrants to the United States to bring out contrasts and nuances in the experiences of different groups based on language, age at immigration and a multiplicity of immigration status categories. We touch on some issues in ethical conduct of research with immigrant communities and conclude with a deep reflection on the power that bioethicists have as insiders in the healthcare industry and the importance, joys and responsibility of teaching the next generation of physicians. Some of Dr. Tuohy's work can be found here:Brian Tuohy, Health Without Papers: Immigrants, Citizenship, and Health in the 21st Century, Social Forces, Volume 98, Issue 3, March 2020, Pages 1052–1073, https://doi.org/10.1093/sf/soz048Rocco, P., & Tuohy, B. (2021). A New Dawn of Bioethics: Advocacy and Social Justice. The American Journal of Bioethics, 22(1), 23–25. https://doi.org/10.1080/15265161.2021.2001105Tuohy B, Jatres J. Researching Those in the Shadows: Undocumented Immigrants, Vulnerability, and the Significance of Research. Am J Bioeth. 2023 Jun;23(6):106-109. doi: 10.1080/15265161.2023.2204053. PMID: 37220350.

Research Renaissance: Exploring the Future of Brain Science
Neurovascular Dysfunction and Neuroinflammation in Alzheimer's with Ashley Carey

Research Renaissance: Exploring the Future of Brain Science

Play Episode Listen Later Aug 27, 2024 40:46


In this episode of Research Renaissance, host Deborah Westphal engages in an enlightening conversation with Ashley Carey, a PhD candidate and 2023 Toffler Scholar at Temple University's Lewis Katz School of Medicine. Ashley's research focuses on the neurovascular dysfunction and neuroinflammation associated with Alzheimer's disease. She shares her journey from aspiring marine biologist to neuroscience researcher, highlighting the importance of cardiovascular health in preventing Alzheimer's.Guest Introduction: Ashley CareyAshley Carey is a PhD candidate and graduate research assistant in Dr. Silvia Fossati's lab at Temple University. She is also a 2023 Toffler Scholar. Her research examines the impact of cardiovascular risk factors on Alzheimer's disease, specifically focusing on neurovascular dysfunction and neuroinflammation. Ashley's work aims to understand how conditions like hyperhomocystinemia and hypertension contribute to Alzheimer's pathology.Key Discussion PointsCareer Motivation and Journey:Ashley's transition from an interest in marine biology to neuroscience during undergraduate schoolThe influence of Dr. Reynolds at Lafayette College in sparking her interest in research.Her decision to focus on Alzheimer's disease during her PhD program at Temple University.Research Focus:Examining cardiovascular risk factors like hyperhomocystinemia and hypertension in Alzheimer's disease.Recent publication on endothelial cell dysfunction due to amyloid beta and homocysteine exposure.The role of cerebral endothelial cells in maintaining vascular integrity and their impact on Alzheimer's pathology.Significant Findings:Additive effects of homocysteine and amyloid beta on endothelial cell dysfunction and increased permeability.The importance of vascular health in preventing early neuronal damage and cognitive decline.Challenges in Alzheimer's Research:Difficulty in obtaining sufficient model samples due to the aging process and cardiovascular risk factors.Complexity of brain vasculature and overlapping pathways complicating research.Funding challenges and the impact of decreased NIA pay lines on dementia research.Interdisciplinary Collaborations:Collaborative work with behavioral testing and biomarker studies.Contributions from the lymphatics department, investigating amyloid deposition in peripheral vessels.Future Directions and Aspirations:Ashley's goal to contribute to neurodegenerative disease research, possibly transitioning into a company or academia.The potential impact of early detection techniques and biomarker screening on Alzheimer's diagnosis and treatment.Mentoring and Funding:Ashley's experience with mentorship from Dr. Fossati and its importance in her research journey.The role of the Toffler Scholar Grant  in supporting her research and supporting career goals.Stay tuned for more episodes of Research Renaissance by subscribing to our podcast. For further information and updates, visit our website at TofflerTrust.org. We welcome your thoughts and suggestions, so feel free to reach out!Until then, onward and upward!To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

Compassion & Courage: Conversations in Healthcare
Promoting Humanism in Healthcare with Dr. Kathy Reeves

Compassion & Courage: Conversations in Healthcare

Play Episode Listen Later Aug 26, 2024 39:45


In today's episode of Compassion & Courage, Marcus invites Dr. Kathy Reeves to discuss the importance of humanism in healthcare and the work of the Gold Foundation in promoting compassionate care. She highlights the need for trust, dignity, and compassion in healthcare and shares her experiences and insights on addressing health disparities and creating meaningful connections with patients. Don't miss this great deep dive into what it means to be a patient focuses provider! Key Moments:00:00 – Introduction and a little about Dr. Reeves02:48 – The Gold Foundation and its Mission06:00 – Promoting Humanism in Healthcare11:40 – The Center for Urban Bioethics and Health Equity22:10 – Violence is contagious, and we can't keep ignoring people27:44 – Witnessing Compassion and the Power of Connection31:40 – Our Voice Matters37:14 – Dr. Kathy Reeves, “Every person deserves dignity, compassion, and trustworthiness, whenever they find themselves in their most vulnerable space.”39:00 – Thank yous and Goodbyes! Resources for you: More communication tips and resources for how to cultivate compassion: https://marcusengel.com/freeresources/ Learn more about The Gold Foundation: https://www.gold-foundation.org/ Connect with Marcus on LinkedIn: https://www.linkedin.com/in/marcusengel/Connect with Dr. Kathy Reeves on LinkedIn: https://www.linkedin.com/in/kathleen-reeves-md-faap-141a1019/Connect with The Gold Foundation: https://twitter.com/GoldFdtn Learn more about Marcus' Books: https://marcusengel.com/store/ Subscribe to our podcast through Apple: https://bit.ly/MarcusEngelPodcast Subscribe to our podcast through YouTube: https://bit.ly/Youtube-MarcusEngelPodcast  More About Dr. Kathy Reeves:Dr. Kathleen Reeves is the President and CEO of The Arnold P. Gold Foundation, the leading national nonprofit organization that champions humanism in healthcare. She is also an adjunct faculty member in the Department of Urban Health and Population Science, the Center for Urban Bioethics, and the Department of Pediatrics at the Lewis Katz School of Medicine at Temple University. Her specialties include the human connection in healthcare, ethics, trauma-informed care, substance misuse, urban health, healthcare professions education, and health equity.She spent 20 years at the Katz School of Medicine before taking the helm of the Gold Foundation. Her leadership positions there included Founding Director, Center for Urban Bioethics; Chair, Department of Urban Health and Population Science; Senior Associate Dean of Student Affairs; and inaugural Senior Associate Dean for the Office of Health Equity, Diversity, and Inclusion. She is a Gold Humanism Honor Society member and was previously recognized as an Honorable Mention for the Gold Foundation's Pearl Hurwitz Humanism in Healthcare Award.Dr. Reeves resides outside of Philadelphia with her husband, Edisio, who is a practicing pediatric gastroenterologist at the Children's Hospital of Philadelphia. They have two children, Ben and Ann Date: 8/26/2024 Name of show: Compassion & Courage: Conversations in Healthcare Episode number and title: Episode 151 – Promoting Humanism in Healthcare

Philadelphia Community Podcast
What's Going On: Better Gun Violence Reporting, Help Us Adopt

Philadelphia Community Podcast

Play Episode Listen Later Jun 7, 2024 29:54 Transcription Available


I adopted by son Christopher in 1992 and I can't begin to tell you how wonderful it's been being an adoptive mom. I was able to manage the extensive costs but there are countless potential parents who simply can't afford adoption. We'll tell you about  wonderful nonprofit called Help us Adopt. First HelpUsAdopt.org, founded in 2007, is a national 501(c)(3) adoption grant program. HelpUsAdopt.org was founded by Becky and Kipp Fawcett as a response to their own personal adoption experience. I speak to Rebecca Snyder Fawcett about the organization that's made adoption more feasible for all families. ​https://www.helpusadopt.org/     You see it every morning on the news. the overnight shooting. The police tape, the bullets encircled by chalk on the ground. New studies show coverage of gun violence can re-traumatize survivors. Two new studies published in Preventive Medicine Reports and BMC Public Health led by corresponding author Jessica H. Beard, MD, MPH, FACS, Associate Professor of Surgery in the Division of Trauma and Surgical Critical Care and Director of Trauma Research at the Lewis Katz School of Medicine at Temple University, more closely examine how reports of community firearm violence are framed on local television news in Philadelphia and the downstream effects of that coverage on the general public's perception of the issue. The Philadelphia Center for Gun Violence Reporting has created  “Better Gun Violence Reporting: A Toolkit for minimizing Harm. 

Philadelphia Community Podcast
Insight Spotlight: Better Gun Violence Reporting with Dr. Jessica Beard

Philadelphia Community Podcast

Play Episode Listen Later Jun 7, 2024 14:26 Transcription Available


You see it every morning on the news. the overnight shooting. The police tape, the bullets encircled by chalk on the ground. New studies show coverage of gun violence can re-traumatize survivors. Two new studies published in Preventive Medicine Reports and BMC Public Health led by corresponding author Jessica H. Beard, MD, MPH, FACS, Associate Professor of Surgery in the Division of Trauma and Surgical Critical Care and Director of Trauma Research at the Lewis Katz School of Medicine at Temple University, more closely examine how reports of community firearm violence are framed on local television news in Philadelphia and the downstream effects of that coverage on the general public's perception of the issue.The Philadelphia Center for Gun Violence Reporting has created  “Better Gun Violence Reporting: A Toolkit for minimizing Harm. 

Passionate Pioneers with Mike Biselli
Fostering Humanism in Healthcare with Dr. Kathy Reeves

Passionate Pioneers with Mike Biselli

Play Episode Listen Later Jun 3, 2024 29:05


This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: Championing compassion and restoring the human connection in healthcare- that's the driving force behind our next guest, Dr. Kathy Reeves, President and CEO of The Arnold P. Gold Foundation. With over two decades of experience in medical education, urban health, and health equity initiatives, Dr. Reeves brings a unique perspective on fostering humanism in healthcare.As the leader of the esteemed Gold Foundation, she is determined to ensure that healthcare professionals provide care that is as compassionate as it is technologically sophisticated.While together, Dr. Reeves shares her vision for creating human-centered spaces, empowering clinicians to prioritize the patient experience, and reshaping the culture of healthcare to prioritize kindness, safety, and trust. Join us for this important and inspiring conversation as Dr. Reeves shares how we can continue to work together to create systems and cultures that support humanistic care for all. Let's go! Episode Highlights:The importance of keeping healthcare human and fostering the human connection, even as technology rapidly advances in the healthcare field.Dr. Reeves' personal experiences as a pediatrician in underserved communities like North Philadelphia, which taught her the value of understanding patients' life contexts to provide truly compassionate care.The Gold Foundation's mission to champion humanism in healthcare through initiatives like the white coat ceremony, Gold Humanism Honor Society, and the new "human-centered spaces" program.Dr. Reeves' vision for changing healthcare metrics to focus on how clinicians connect with patients, rather than just patient volume.The need to integrate the voice of local communities into medical education to bridge the gap between academic medical centers and the populations they serve.About our Guest: Dr. Kathleen Reeves is the President and CEO of The Arnold P. Gold Foundation, the leading national nonprofit organization that champions humanism in healthcare. She is also an adjunct faculty member in the Department of Urban Health and Population Science, the Center for Urban Bioethics, and the Department of Pediatrics at the Lewis Katz School of Medicine at Temple University. Her specialties include the human connection in healthcare, ethics, trauma-informed care, substance misuse, urban health, healthcare professions education, and health equity.She spent 20 years at the Katz School of Medicine before taking the helm of the Gold Foundation. Her leadership positions there included Founding Director, Center for Urban Bioethics; Chair, Department of Urban Health and Population Science; Senior Associate Dean of Student Affairs; and inaugural Senior Associate Dean for the Office of Health Equity, Diversity, and Inclusion. She is a Gold Humanism Honor Society member and was previously recognized as an Honorable Mention for the Gold Foundation's Pearl Hurwitz Humanism in Healthcare Award.Dr. Reeves earned her Bachelor of Science degree from Juniata College, graduated from the Sidney Kimmel College of Medicine at Thomas Jefferson University, and completed her Pediatric Residency at the Cincinnati Children's Hospital Medical Center. She is board certified in both general pediatrics and pediatric hospital medicine and continues to practice as a pediatric hospitalist. She has served in the leadership team as part of the Northeast Group on Student Affairs within the American Association of Medical Colleges.Dr....

Psychobabble
Psychiatric Drugs Unmasked with Robert Whitaker

Psychobabble

Play Episode Listen Later May 15, 2024 64:27


Robert Whitaker challenges the prevailing narrative surrounding mental illness, particularly the widely accepted theory of chemical imbalances. Through meticulous analysis and compelling evidence, he presents a thought-provoking critique. Furthermore, Whitaker examines the limitations of antidepressants, highlighting their short-term efficacy and lack of sustained improvement over time. In our discussion, we explore a range of topics within the realm of psychiatric treatment, including medication for ADHD and the valid questions being posed to the diagnosis and treatment of Schizophrenia.Robert Whitaker authored "Mad in America," named one of Discover magazine's best science books in 2002. His work "Anatomy of an Epidemic" received the 2010 Investigative Reporters and Editors book award for investigative journalism. He serves as the publisher of madinamerica.com and holds a Clinical Assistant Professor (Adjunct) position at Temple University's Lewis Katz School of Medicine, Department of Psychiatry and Behavioral Science.Chapters:(00:00) Introduction and background of Robert Whitaker(02:03) Investigating Corruption in Psychiatric treatment(07:08) Chemical Imbalances in Mental Health: Challenging Narratives(13:20) Antidepressant Limitations and Long-Term Efficacy Concerns(15:36) Informed Consent Issues in Clinical Psychiatry: Addressing Concerns(31:59) Medicalization of Mental Disorders: Understanding the Trend(36:19) Pharmaceutical Company Influence in Psychiatry: Exploring Impact(40:36) Mental Health Treatment Rethink: Innovative Approaches(43:26) Critiques of the Psychiatric Diagnostic System: Evaluating Accuracy(49:30) Long-Term Outcomes of Psychiatric Drug Treatment: Insights Revealed(55:49) Schizophrenia Evolution: From the 1930s to Modern Perspectives Get full access to Psychobabble at hannahspier.substack.com/subscribe

The Treat Addiction Save Lives Podcast
Special Episode from the 55th Annual ASAM Conference: Dr. Ian Latham

The Treat Addiction Save Lives Podcast

Play Episode Listen Later Apr 15, 2024 5:21


Ian Latham, MD, sat down with our host, Zach, at ASAM's 55th Annual Conference. In this special episode, he speaks about his journey into the field of addiction medicine and his experience as an addiction medicine fellow at the University of Minnesota. Dr. Latham divulges what he enjoys about attending ASAM's annual conference and his impressions from this year's conference, in particular. He talks about the benefits of being a Ruth Fox Scholar and offers advice for other fellows or anyone thinking of entering the field of addiction medicine. Dr. Latham also shares his feelings about the state of the addiction medicine community in Minnesota. Dr. Latham is an addiction medicine fellow at the University of Minnesota; he recently completed his residency in family medicine at the University of Minnesota/North Memorial Residency Program. He completed his undergraduate education in molecular biology at the University of Wisconsin – Madison and his medical education at the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania, where he participated in research in narrative medicine, trauma-informed addiction care, and mobile services for buprenorphine treatment. Dr. Latham has a particular interest in working with patients who identify within the LGBTQ+ community, the management of behavioral addictions, and the treatment and prevention of viral disease among people living with addiction.   Links: ASAM's Annual Conference Information Ruth Fox Scholarship Program Information American Society of Addiction Medicine (ASAM)   If you or someone you know is struggling with addiction, you are not alone. Treatment is available and recovery is possible. Visit ASAM's Patient Resources page for more information. The information shared in this podcast episode is for educational purposes only and should not be taken as medical advice. The views expressed in this podcast may not be those of the host or ASAM management.

Daily Remedy
Discussing Medicine on Fire with Dr. Arthur Lazarus

Daily Remedy

Play Episode Listen Later Mar 8, 2024 35:25


We discuss Dr. Arthur Lazarus's latest book: Medicine on Fire: A Narrative Travelogue. https://www.amazon.com/Medicine-Fire-Arthur-Lazarus-MBA/dp/1663257272 Arthur Lazarus is a former Doximity Fellow, a member of the editorial board of the American Association for Physician Leadership, and an adjunct professor of psychiatry at the Lewis Katz School of Medicine at Temple University in Philadelphia, PA. He is the author of Every Story Counts: Exploring Contemporary Practice Through Narrative Medicine and Medicine on Fire: A Narrative Travelogue. #lazarus #doximity #medicine #fire

Don't Force It: How to Get into College without Losing Yourself in the Process
Dr. Neha Pathak and Dr. Joyce Varughese: Education and the children of immigrants

Don't Force It: How to Get into College without Losing Yourself in the Process

Play Episode Play 30 sec Highlight Listen Later Feb 15, 2024 32:47


In today's episode, I engage in a compelling conversation with two dear friends and accomplished professionals, Dr. Neha Pathak and Dr. Joyce Varughese, on navigating the pressures of college and societal expectations. They offer insightful advice for the next generation, urging a pursuit of passion over predefined paths. Join us as they candidly discuss the complexities of finding contentment amid the pursuit of success.BioDr. Joyce Varughese is a highly accomplished gynecologic oncology surgeon, specializing in pre-cancers and cancers of the female reproductive tract. Having graduated from Harvard College, Yale University, and Albert Einstein College of Medicine, she is a clinical assistant professor at Rowan University and Temple University's Lewis Katz School of Medicine. Dr. Varughese is recognized for her expertise in robotic surgery, complemented by her dedication to teaching and involvement in international medical initiatives. Currently serving as the Medical Director of Gynecologic Oncology at Capital Health, she is also a devoted wife and mother who enjoys running, hiking, and family time.Neha Pathak MD, FACP, DipABLM is board certified in both internal medicine and lifestyle medicine andworks as Chief Physician Editor for Health and Lifestyle Medicine and host of WebMD's HealthDiscovered podcast. She reports on topics related to lifestyle, climate change, and environmentalimpacts on health for WebMD and Medscape, and is a regular contributor to Yale Climate Connections.She is a member of the American College of Lifestyle Medicine board of directors and Chair of the GlobalSustainability Committee. Dr. Pathak is also a lecturer at the Yale School of Public Health where shefacilitates coursework on climate change and health. She is a founding member of Georgia Clinicians forClimate Action. She has been invited to join the National Academy of Medicine's Communicating aboutClimate Change and Health Project expert panel. Through all of her work, she hopes to educatehealthcare professionals and the public about the health impacts of climate change and environmentalpollution and the health benefits of climate action. She lives in Atlanta with her husband and children.Access free resources and learn more about Sheila and her team at Signet Education at signeteducation.com or on LinkedIn at https://www.linkedin.com/in/sheilaakbar/.

Built Not Born
#129 - Tricia Burdo, PhD - The Relentless Pursuit to Cure HIV / AIDS

Built Not Born

Play Episode Listen Later Jan 12, 2024 49:32


Tricia Burdo, PhD is the Professor and Vice Chair of Microbiology, Immunology, and Inflammation at Temple University's Lewis Katz School of Medicine in Philadelphia. Dr Burdo and I discuss the decades long search for the cure for HIV / AIDS. We discuss the latest treatments, experimental therapies, and the latest research in the search to cure to one of the most mysterious diseases known to humankind.How close are we to a cure? Tune in to find out.Connect with Tricia Burdo, PhD:LinkedIn: Tricia Burdo, PhDWebsite: Tricia Burdo, PhD“Life is Built, Not Born.” Joe Ciccarone#Episode129

See, Hear, Feel
EP93: Dr. Jules Lipoff on why medicine needs creativity

See, Hear, Feel

Play Episode Play 19 sec Highlight Listen Later Dec 20, 2023 12:45 Transcription Available


Learn how it is that Dr. Lipoff and I ended up connecting to have this conversation! (for the impatient ones [like me], find this info at 5:44). Dr. Jules Lipoff, MD is a dermatologist practicing in northwest Philadelphia and Clinical Associate Professor (Adjunct) in the Lewis Katz School of Medicine at Temple University.  He runs a PRIDE clinic (PRoviding Integrated Dermatology for Everyone) serving both LGBT patients and patients living with HIV for every major health system and LGBT center in the Philadelphia area.  He also serves as senior subspecialist telemedicine consultant for Medecins Sans Frontieres and writes as a columnist for the Philadelphia Inquirer.  In addition to his over 100 published academic articles, his creative work includes podcasts, screenplays, short films, medical consulting for television, and beyond the Inquirer, his writing has appeared in The New York Times, The Los Angeles Times, Slate, Vox, The Hill, STAT News, and JAMA.

The Podcast by KevinMD
Navigating challenges in modern medicine through storytelling

The Podcast by KevinMD

Play Episode Listen Later Dec 1, 2023 18:55


Join Arthur Lazarus, an adjunct professor of psychiatry and the author of Every Story Counts: Exploring Contemporary Practice Through Narrative Medicine. In this episode, we delve into the profound significance of storytelling and narrative in the medical field. Lazarus sheds light on the challenges faced by physicians in today's ever-evolving health care landscape, addressing topics such as burnout, physician advocacy, and the healing power of resilience. Arthur Lazarus is a former Doximity Fellow, a member of the editorial board of the American Association for Physician Leadership, and an adjunct professor of psychiatry at the Lewis Katz School of Medicine at Temple University in Philadelphia, PA. He discusses his book, Every Story Counts: Exploring Contemporary Practice Through Narrative Medicine. Our presenting sponsor is Nuance, a Microsoft company. Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care's biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself. The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational. Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/zpC1OT Powered by CMEfy.

Informatics in the Round
Getting ”Dis”ed: Battling Misinformation and Disinformation on Social Media

Informatics in the Round

Play Episode Listen Later Sep 19, 2023 64:57


In this episode, we tackle an all-too-familiar topic: misinformation. Since the COVID-19 pandemic, we have seen how technology and social media can be used to both spread health information awareness and popularize misinformation. The question remains: in the age of technology, how can we be sure about the validity of the information we are receiving online, and how can we all be vigilant against the spread of misinformation? To help us, we had the wonderful Evan Thornburg join us for today's podcast. Evan is a bioethicist and health equity officer for the City of Pennsylvania's Department of Public Health. In the past, they've also worked in the Philadelphia Mayor's Office as Deputy Director of LGBT. After completing a Master's of Arts in Urban Bioethics at Temple University's Lewis Katz School of Medicine and writing their thesis on the spread of misinformation, Evan took to TikTok, utilizing the platform to share their knowledge about bioethics, comment on current health news, and challenge the online community to be discerning about how they absorb and converse about health information. You can find Evan on TikTok at EVN the (Bio) Ethicist. We loved talking with Evan, and we hope you come out of this episode with some practical tools to help you filter the information you see on social media! Learn more about ethical research conduct from government websites such as the National Institutes of Health, the National Science Foundation, and the American Psychological Association.  Check out what the American Board of Internal Medicine has to say about the rise of misinformation: -https://blog.abim.org/an-update-on-our-efforts-to-address-medical-misinformation/ -https://blog.abim.org/new-paper-recommends-creating-a-durably-funded-infrastructure-for-media-monitoring-and-effective-coordinated-responses-to-medical-misinformation/ Learn more about the work Desmond Upton Patton is doing with SAFELab here: https://www.asc.upenn.edu/research/centers/safe-lab Make sure to follow our Instagram, Twitter, Threads, TikTok, and Facebook accounts so you can stay up to date on all our new content. Also don't forget to follow us on Twitter @kbjohnsonmd and @htbland21. You can also find us wherever you typically get your podcasts. Thanks for listening! Instagram: @infointhernd Twitter: @infointhernd  Threads: @infointhernd TikTok: @infointhernd  Facebook: @Informatics in the Round  Website: https://www.kevinbjohnsonmd.net/podcast

Clinician's Roundtable
Gene-Editing: The Potential Key to Eliminating HIV

Clinician's Roundtable

Play Episode Listen Later Aug 3, 2023


Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kamel Khalili, PhD Scientists at Temple University's Lewis Katz School of Medicine have identified a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality. Find out how this recent discovery could get us one step closer to a cure for HIV with Dr. Charles Turck and Dr. Kamel Khalili, the Laura H. Carnell Professor in the Department of Neuroscience and Chair of the Department of Microbiology, Immunology & Inflammation.

Midday
Alzheimer's rates are high in Md., but a new drug brings hope

Midday

Play Episode Listen Later Jul 26, 2023 23:00


More than six and a half million Americans suffer from Alzheimer's Disease, a debilitating and incurable illness. It robs people of their memory and their thinking skills, and ultimately leads to the inability to perform basic tasks. Using the Accelerated Approval Pathway, the Food and Drug Administration approved a drug called lecanemab, sold as Leqembi, which has slowed the progression of the disease in some patients in clinical trials. Joining Tom to talk about it is Dr. Leah Croll, an assistant professor of neurology at the Lewis Katz School of Medicine at Temple University. A couple of weeks after the news of this new drug appeared, the Alzheimer's Association announced the results of a new study about who gets Alzheimer's, and where those populations live. It turns out that Baltimore and Prince George's County are places with a high incidence of the disease. Joining Tom to discuss this is Dr. Kumar B. Rajan a Professor in the Department of Internal Medicine and the Director of the Rush Institute for Healthy Aging in Chicago. He's also Section Chief of Community and Nutritional Epidemiology. He is the lead author of the study.Email us at midday@wypr.org, tweet us: @MiddayWYPR, or call us at 410-662-8780.

ResetMD
Dr Darilyn Moyer - "Be Curious - How to Make Decisions in your Career"

ResetMD

Play Episode Listen Later Jul 19, 2023 29:34


This episode was originally released September 2021. Darilyn V. Moyer, MD, MACP, FRCP, FIDSA is the Executive Vice President and Chief Executive Officer of the American College of Physicians (ACP). She has served on ACP's Board of Regents, which manages the business and affairs of ACP and is the main policy-making body of the College, chaired ACP's Board of Governors, and served as Governor of ACP's Pennsylvania Southeastern Chapter. Prior to becoming ACP's EVP and CEO, Dr. Moyer was a Professor of Medicine, Executive Vice Chair for Education in the Department of Medicine, Internal Medicine Residency Program Director and Assistant Dean for Graduate Medical Education at Lewis Katz School of Medicine at Temple University. She was previously the Co-Faculty Advisor for the Temple University School of Medicine Internal Medicine Interest Group and for the Temple University School of Medicine Student Educating About Healthcare Policy Group. Dr. Moyer currently practices part time at the Temple University Internal Medicine Associates. In this episode we discuss her resets into medical education and then to advocacy with the ACP. She shares her thoughts on finding what you are meant to do in your career.  She discusses what supports her wellness and gives advice for women in medicine.  She ends with the mantra of "Bring your Best to Whatever You Do Everyday."  Pearls of Wisdom: 1. Take Care of Yourself- in whatever way works for you.  Know what Recharges you.  2. Reach Out to People to hear their story.  Be Curious and Listen.   3. Create Community inside and outside of medicine. 4. Write Down and Examine your short and long-term goals.

Leading Improvements in Higher Education with Stephen Hundley
s03e07: Discussing Students' Basic Needs with Colleagues from The Hope Center for College, Community, and Justice at Temple University

Leading Improvements in Higher Education with Stephen Hundley

Play Episode Listen Later Apr 17, 2023 53:08


In this episode, we spend time discussing students' basic needs with colleagues from The Hope Center for College, Community, and Justice at Temple University.  Our guests are Anne Lundquist, Stacy Priniski, and Josh Williams.  Anne is Director and Assistant Professor at The Hope Center in the Lewis Katz School of Medicine at Temple.  Stacy is a Senior Evaluation Associate at The Hope Center.  Josh is a practitioner-researcher at The Hope Center.Learn more about The Hope Center at:hope.temple.edu. This season of Leading Improvements in Higher Education is sponsored by the Center for Assessment and Research Studies at James Madison University; learn more at jmu.edu/assessment.Episode recorded: March 2023.  Host:  Stephen Hundley.  Producers:  Chad Beckner, Caleb Keith, and Shirley Yorger.  Original music:  Caleb Keith.  This award-winning podcast is a service of the Assessment Institute in Indianapolis; learn more at assessmentinstitute.iupui.edu.

Connecting ALS
Expanding Diversity in Clinical Trials…

Connecting ALS

Play Episode Listen Later Apr 13, 2023 18:33


This week, Jeremy welcomes Dr. Terry Heiman-Patterson, professor of neurology at the Lewis Katz School of Medicine at Temple University and director of the Temple MDA/ALS Center of Hope, to talk about her work looking into ways to expand access to clinical trials for historically underserved populations. Learn more about The ALS Association's Clinical Trial Capacity Awards program at https://www.als.org/stories-news/als-association-grants-nearly-5-million-boost-clinical-trial-capacity-and-speed

The Kinked Wire
JVIR audio abstracts: April 2023

The Kinked Wire

Play Episode Listen Later Mar 28, 2023 16:11


This recording features audio versions of April 2023 Journal of Vascular and Interventional Radiology (JVIR) abstracts:Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months ReadLateral Subdermic Venous Plexus Insufficiency: The Association of Varicose Veins with Restless Legs Syndrome and Nocturnal Leg Cramps ReadAdverse Events Associated with Intra-Arterial Administration of Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis ReadPreoperative Arterial Embolization for Heterotopic Ossification of the Hip Read Multi-institutional Retrospective Study of Percutaneous Cholangioscopy-Assisted Lithotripsy for Inoperable Calculous Cholecystitis ReadPercutaneous Cystic Duct Interventions and Drain Internalization for Calculous Cholecystitis in Patients Ineligible for Surgery Read JVIR and SIR thank all those who helped record this episode:Host and audio editor:Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaAbstract readers: Rommell Noche, Frank H. Netter MD School of Medicine at Quinnipiac University, ConnecticutSydney Levy, University of Florida College of MedicineShalom Mammen, Lewis Katz School of Medicine at Temple University, PennsylvaniaPriya Gupta, MBS, Rutgers New Jersey Medical SchoolAnna Hu, George Washington University School of Medicine and Health Sciences, D.C.Khaleel Quasem, Michigan State University College of Human Medicine  ©  Society of Interventional RadiologySupport the show

MesoTV Podcast: Conversations Impacting the Mesothelioma Community
Which patients can benefit from surgery, how mesothelioma differs from lung cancer + more!

MesoTV Podcast: Conversations Impacting the Mesothelioma Community

Play Episode Listen Later Mar 2, 2023 62:08


We meet with Dr. Joseph Friedberg, a thoracic surgeon at Temple University Hospital-Main Campus and Fox Chase Cancer Center. Joseph Friedberg, MD, FACS, is Thoracic Surgeon-in-Chief of Temple University Health System, Vice Chair of Surgical Services for the Department of Thoracic Medicine and Surgery, Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, and Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. He is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma Applied Research Foundation. www.curemeso.org. MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Maune Raichle Hartley French & Mudd, LLC (MRHFM); Bristol Myers Squibb; Novocure, Merck, The Gori Law Firm, TCR2, AstraZeneca, Early Lucarelli Sweeney & Meisenkothen. Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv.

CytopathPod
Cytopathology Program Director Toolkit: Board Review and Knowledge Assessment

CytopathPod

Play Episode Listen Later Jan 26, 2023 20:38


Cytopathology Program Director Toolkit: Board Review and Knowledge Assessment Dr. Vanda Torous, Chair of the ASC Cytopathology Program Directors Committee, interviews Dr. Israh Akhtar on her experience and recommendations on cytopathology board review and knowledge assessment in this episode of our series Cytopathology Program Director Toolkit. Dr. Akhtar is a professor of pathology and laboratory medicine at the Lewis Katz School of Medicine at Temple University where she is a cytopathologist and surgical pathologist with interests in breast, gynecologic, and pulmonary pathology among others. She is also the director of surgical pathology at Temple. Dr. Akhtar has served on several committees of national organizations including being a member of the ASC Program Director Committee for 4 years. For resources click here. Sponsored by the ASC Cytopathology Program Directors Committee. 

The Kinked Wire
JVIR audio abstracts: February 2023

The Kinked Wire

Play Episode Listen Later Jan 25, 2023 12:26


This recording features audio versions of February 2023 Journal of Vascular and Interventional Radiology (JVIR) abstracts:A Review of Professional Liability in IR: Sweeping the Mines ReadPortal Vein Recanalization for Noncirrhotic Portal Vein Cavernous Transformation: Transjugular Intrahepatic Portosystemic Shunt Creation versus Portal Vein Stent Placement ReadEndovascular Lymphatic Decompression via Thoracic Duct Stent Placement for Refractory Ascites in Patients with Cirrhosis: A Pilot Study ReadThe Effect of Protective Coil Embolization of Penile Anastomoses during Prostatic Artery Embolization on Erectile Function: A Propensity-Matched Analysis ReadGunther Tulip Filter Strut Penetration: Benign Long-Term Follow-up ReadOutcomes after Transgastric Drainage of Pancreatic Duct Leaks ReadJVIR and SIR thank all those who helped record this episode:Host and audio editor:Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaAbstract readers:Shalom Mammen, Lewis Katz School of Medicine at Temple University, PennsylvaniaNader Osman, Alfaisal University, Saudi ArabiaDaniel Kim, Edward Via College of Osteopathic Medicine, VirginiaSiddhi Hegde, MBBS Massachusetts General HospitalAndrew Han, MEd, Liberty University College of Osteopathic Medicine, VirginiaBridget Kowalczyk, Saint Louis University School of Medicine, Missouri  ©  Society of Interventional RadiologySupport the show

The Kinked Wire
JVIR audio abstracts: January 2023

The Kinked Wire

Play Episode Listen Later Dec 30, 2022 18:41


This recording features audio versions of December 2022  Journal of Vascular and Interventional Radiology (JVIR) abstracts:Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies ReadComparison of Bolus Versus Dual-Syringe Administration Systems on Glass Yttrium-90 Microsphere Deposition in an In Vitro Microvascular Hepatic Tumor Model ReadSalvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures ReadClinical Outcomes of Transarterial Embolization for Chronic Achilles Tendinopathy Refractory to Conservative Treatment: A Pilot Study ReadIntra-articular Injection of Bone Marrow Concentrate for Treatment of Patellofemoral Osteoarthritis: Preliminary Results Utilizing an Ultrasound-Guided Marrow Harvesting Technique ReadPercutaneous Radiofrequency Sympatholysis in the Treatment of Primary Palmar Hyperhidrosis: A Retrospective Case-Controlled Study of Rib-Based Anatomical Targeting ReadUnplanned 30-Day Readmissions after Management of Submassive and Massive Acute Pulmonary Embolism: Catheter-Directed versus Systemic Thrombolysis Read JVIR and SIR thank all those who helped record this episode:Host and audio editor:Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaAbstract readers:Jacob Knittel, Creighton University School of Medicine Phoenix Regional Campus, ArizonaAleksandr Zyskin, MS, Eastern Virginia Medical SchoolAnna Hu, George Washington University School of Medicine, District of ColumbiaShunn Theingi, Lewis Katz School of Medicine, PennsylvaniaEric Juang, MS, Creighton University School of Medicine Phoenix Regional Campus, ArizonaAnne-Marie Nwajei, MS, The Chicago Medical School at Rosalind Franklin University of Medicine and ScienceAndrew Han, MEd, Liberty University College of Osteopathic Medicine, Virginia ©  Society of Interventional RadiologySupport the show

STFM Academic Medicine Leadership Lessons
Learn from Every Experience, with Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL

STFM Academic Medicine Leadership Lessons

Play Episode Listen Later Dec 5, 2022 44:33


With infectious enthusiasm, Dr Margot Savoy, senior vice president of education for the American Academy of Family Physicians (AAFP), talks about the ongoing collaborative efforts of the family of family medicine organizations to support the educational needs of the entire family medicine community, whether with CME or other educational opportunities. Gleefully drawing on her experience as a medical student who “just wanted to be a real doctor,” Dr Savoy brings good humor into the journey so many have taken, whether as students and residents, or preceptors and faculty.Hosted by Saria Carter Saccocio, MD.Copyright © Society of Teachers of Family Medicine, 2022Guest Bio:Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL, (she/her) is Senior Vice President of Education for the American Academy of Family Physicians, Associate Professor(adj) of Family & Community Medicine and Urban Bioethics at the Lewis Katz School of Medicine, and Associate Professor (adj) at the Maurice Kornberg School of Dentistry at Temple University. Dr. Savoy oversees the AAFP education portfolio from medical school through continuing medical education, the accreditation system, journal media and the Center for Diversity & Health Equity. She also is the lead for Physician Health First, the AAFP's physician well-being program.Dr. Savoy graduated from the University of Maryland School of Medicine in 2002, completed Family Medicine Residency Program at the Crozer-Keystone Family Medicine Residency Program (Springfield, PA) in 2005 and graduated from the University of North Carolina Chapel Hill Gillings School of Global Public Health in 2008 with a Masters degree in Public Health in Public Health Leadership with a focus on Public Health Practice. She is certified by the American Board of Family Medicine, the Certifying Commission in Medical Management, the American Board of Medical Quality and is a Fellow of the American Academy of Family Physicians, American Association of Physician Leaders and the Advisory Board Company. Resources:AAFP Resources:AAFP Center for Diversity and Health Equity AAFP Commission on Diversity, Equity, and Inclusiveness in Family Medicine (CDEI-FM)Physician Health First - AAFP Resource Publications:AAFP PublicationsSTFM Journals STFM Faculty Development:Faculty for Tomorrow WebinarsTips for New FacultyFaculty Development DeliveredSTFM Faculty Development Starter Package for ResidenciesShow Notes: https://stfm.org/stfmpodcast122022

Life Coaching for Women Physicians
132. Exercise/Fat Loss Pitfalls: Top 10 Reasons Why You Haven't Committed Yet

Life Coaching for Women Physicians

Play Episode Listen Later Oct 26, 2022 33:09


We all use excuses not to commit to an exercise or health plan. But the truth is, that's all they are: excuses. If you find yourself full of excuses not to commit, you're not alone – it's a widespread occurrence. Dr. Mark Novitsky joins me to discuss the top ten reasons we don't commit to a fitness or health plan.   The Top 10 Reasons Why You Haven't Committed to Exercise Time Mistrust Disappointment  Shame for Needing Help Overwhelm Resistance  Always Putting Others First Procrastination Discounting Yourself Money   About Dr. Mark Novitsky Dr. Mark Novitsky is a Board Certified Child and Adolescent Psychiatrist and Board Certified Adult Psychiatrist.  Dr. Mark believes that effective work with children involves working closely with parents, schools, and other medical/mental health providers - to achieve a joint goal of optimizing a child's well-being.   His extensive clinical experience includes, but is not limited to: Attention Deficit Hyperactivity Disorder (ADHD) Mood Disorders Depressive disorder Bipolar disorder Anxiety Disorders and Obsessive-Compulsive Disorder (OCD) Childhood trauma/Post-traumatic stress disorder (PTSD) Oppositional Defiant Disorder and Conduct Disorder Autism Spectrum Disorder Substance Use Disorders Dr. Mark is an adjunct faculty for Lewis Katz School of Medicine at Temple University's Department of Psychiatry.  He was previously the Corporate Medical Director for one of Philadelphia's largest non-profit Child Mental Health Organizations.  He is a graduate of The Beck Initiative, a joint collaboration between The Aaron T. Beck Center at The University of Pennsylvania and CBH/DBHIDS, for Cognitive Therapy and Research.  For the last several years, he has had the privilege of working at Washington DC's premier psychiatry office, Potomac Psychiatry, as a child and adolescent psychiatrist, adult psychiatrist, and a forensic expert witness providing court testimony in the DC, Maryland, and Virginia region.  Potomac Psychiatry has been featured as the Faces of Washington, in The Washingtonian Magazine. Dr. Mark grew up in the Philadelphia suburbs, received his undergraduate degree from Wake Forest University, and attended both medical school and psychiatry residency at Temple University School of Medicine (now Lewis Katz School of Medicine at Temple University). He served as Chief Resident in his third year of residency at Temple.  He completed Child and Adolescent fellowship at Thomas Jefferson University, where he served as Chief Fellow.   During his fellowship, Dr. Mark was awarded a research grant.  He has several publications in peer-reviewed journals and has presented his research at the annual meetings of both the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP).  In 2013, his Adherence in Pediatric Psychopharmacology-A Multi-dimensional Perspective and Approach was a docent selection of the American Academy of Child and Adolescent Psychiatry. Dr. Mark has taught hundreds of medical students and residents, and most recently was the lead Child and Adolescent Psychiatrist in a non-profit public outreach campaign to Philadelphia schools through Michael's Giving HAND (Micahel P. Donatucci Foundation, Inc ), teaching school administration, teachers, counselors, and parents about how to identify and address Depression, Anxiety, Substance abuse, and Bullying.   When he's not working, Dr. Mark enjoys spending time with his family, walking around Longwood Gardens, checking out live music, and being outdoors with his Labradoodle.   Prioritize Your Fitness The number one excuse we hear is that people don't have time to exercise. But making the time to take on healthy behaviors can actually make you more productive in all other areas of your life.  It really comes down to having well-defined goals, setting your priorities, and sticking to them. I find this especially helpful if you feel you've failed in the past – you simply didn't have these goals as your priorities then, which is okay. I understand that it can feel overwhelming to try to start a fitness routine when you already have so much going on. Letting the overwhelming feeling win is easy, but by setting out your top three priorities daily, you can start getting a grip on it all.   Put Yourself First As women physicians, we're used to putting everyone else before ourselves. This is counterproductive! By putting yourself first, you fill your cup, giving you so much more energy, space, and opportunity to serve the other people and priorities in your life.  One of the other big excuses for fitness is procrastination. We tend to procrastinate on what isn't a priority for us. What if you did make your health and fitness a priority? Imagine what could change. I want you to invest in yourself. I want you to put yourself first. I want you to prioritize your health, wellness, fitness, and happiness. You are so worth it. Do your decisions align with your top priorities? What steps can you make this week to stop using any of these top ten excuses not to exercise? Let me know in the comments on the episode page.   In This Episode  How often we all use time as an excuse not to do something [4:00] What happens when we create the time to take on healthy behaviors [5:15] The importance of a clearly defined goal [8:15] What happens when you change your thought process about failure and priorities [11:30] How to prioritize exercise when you already have so much else going on [15:45] Why you are least productive when you're overwhelmed [16:45] What transformation happens when you put yourself first [23:00] Why we procrastinate on our health and fitness goals [24:45] Why you need to invest in yourself and your health [28:45]   Quotes “There are 24 hours in a day, and that's never going to change. It's not actually about the time, it's about how you use the time and what you choose to use your time on. It all comes down to priorities.” [3:26]  “We set ourselves up for disappointment. We set ourselves up for failure if we don't go ahead and define what it is that we want, and we agree to trust the process. That's why it's important that we know what we're getting ourselves into. Even if we get ourselves into something that's not comfortable, we can trust ourselves to be successful because we know what we're trying to achieve.” [9:16] “It starts with us. We have to agree that we are worth it, and there is no more putting a hold on ourselves.” [17:47] “It is so easy to try and put others first, but you will show up as your best self if you are putting yourself first. You are the most important person in the room.” [23:06] “The investment that you make in yourself and your health is priceless.” [28:43]   Resources Mentioned Transform Check out the full episode page here Find Life Coaching for Women Physicians Online Follow Dr. Ali Novitsky on Facebook | Instagram  Subscribe to Life Coaching for Women Physicians on Apple Podcasts Podcast production by the team at Counterweight Creative   Related Episodes Episode 128: Rethinking Weight Loss Episode 129: So Much More Than Weight Loss Part 1 Episode 130: So Much More Than Weight Loss Part 2

The Kinked Wire
JVIR audio abstracts: October 2022

The Kinked Wire

Play Episode Listen Later Sep 29, 2022 18:24


This recording features audio versions of October 2022  Journal of Vascular and Interventional Radiology (JVIR) abstracts:Percutaneous Hemodialysis Fistula Creation ReadLong-Term Results from the Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access ReadChanges in the National Endovascular Management of Femoropopliteal Arterial Disease: An Analysis of the 2011–2019 Medicare Data ReadPredictors of Clinical Outcomes of Pharmacomechanical Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Analysis of a Multicenter Randomized Trial ReadCerebral Venous Sinus Thrombosis Treated with Vacuum Aspiration Thrombectomy without Thrombolysis: A Descriptive and Retrospective Study of 5 Years' Experience at a Single Center ReadInterventional Radiologists Achieve Equivalent Outcomes and Lower Costs for Totally Implantable Venous Access Device Placement Compared to Operating Room Placement ReadComparison between Antegrade versus Retrograde Ureteral Stent Placement for Malignant Ureteral Obstruction ReadRadiofrequency Ablation versus Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Awaiting Liver Transplant: An Analysis of the Scientific Registry of Transplant Recipients ReadJVIR and SIR thank all those who helped record this episode:Host:Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaAudio editor:Anne-Marie Nwajei, MS, The Chicago Medical School at Rosalind Franklin University of Medicine and Science, IllinoisAbstract readers:Joseph Moirano, The Zucker School of Medicine at Hofstra/Northwell, New YorkTy Mattinson, University of Washington School of MedicineShunn Theingi, Lewis Katz School of Medicine at Temple University, PennsylvaniaAshley Lau, A.T. Still University, MissouriJ.C. Panagides, Harvard Medical School, Massachusetts Anna Hu, George Washington University School of Medicine and Health Sciences, D.C. Talal Mourad, University of Illinois at PeoriaJohn Schanz, Thomas Jefferson University, Pennsylvania©  Society of Interventional RadiologySupport the show

Our Delaware Valley Podcast
Making Strides for Breast Cancer Research and Awareness

Our Delaware Valley Podcast

Play Episode Listen Later Sep 13, 2022 29:34


Jason Plaia, Director of Development for the American Cancer Society (ACS) of Greater Philadelphia, South Jersey and Delaware; Morgan Robinson, Associate Director of Development Making Strides Against Breast Cancer and a Team Leader in the Greater Philadelphia Walk, and Dr. Curtis Miyamoto, Chairperson of Radiation Oncology, Lewis Katz School of Medicine, Temple University and Associate Director for Clinical Services, Fox Chase Cancer Center at Temple University Hospital, ACS Greater Philadelphia Board of Directors Member and Real Men Wear Pink Ambassador discussed breast cancer and the services and research funding provided by the ACS. To learn more about the American Cancer Society, its tips and screening recommendations, research funding and local services go to CANCER.org.  For 24 hour support, call 800-227-2345. There are three Making Strides walks scheduled for Delaware, Philadelphia and South Jersey, as well at locations across the region, to find a walk nearest you and learn how you can become involved, visit MakingStridesWalk.org. To learn more about Real Men Wear Pink and support their efforts visit realmenwearpinkacs.org.

The Good Word with Tisha Lewis
The Good Word: Dr. Stephanie Hack

The Good Word with Tisha Lewis

Play Episode Listen Later Sep 12, 2022 21:50


The Good Word podcast host Tisha Lewis reconnects with her childhood friend Dr. Stephanie Hack to discuss maternal health, the disproportionate rate of maternal mortality among Black women, faith and religion and having a voice in the doctor's office. Dr. Hack is a board-certified obstetrician and gynecologist with a special interest in health education and women's health advocacy. While obtaining her medical degree from Lewis Katz School of Medicine at Temple University, she completed a master's degree in public health to broaden her reach. She has developed multiple community youth programs, facilitated local community health initiatives and served as a commissioner for the D.C. Lactation Commission. During her residency at Georgetown University Hospital and Washington Hospital Center, she further developed her skills as a practitioner and educator. As a former television host for BET, she hopes to continue to use her voice to bring awareness to issues confronting women both regionally and around the world. Dr. Hack is also the host and creator of the Lady Parts Doc podcast.  SUBSCRIBE TO THE GOOD WORD PODCAST NOW! 

Breathe Easy
Interventional Pulmonology Career Pathways (Thoracic Oncology Assembly): Balancing IP with translational cancer research and making the switch to industry

Breathe Easy

Play Episode Listen Later Aug 23, 2022 23:58


GuestDr. Edmund MoonMedical Director Cell/Gene Therapy Program GlaxoSmithKlineFormerly Associate Professor of Medicine at the Hospital of the University of PennsylvaniaSection of Interventional Pulmonology HostDr. Mark Weir M.B Ch.B Assistant Professor Thoracic Medicine at Lewis Katz School of MedicineTemple University

Admissions Straight Talk
An Interview With the Temple Katz School of Medicine Admissions Dean

Admissions Straight Talk

Play Episode Listen Later Jun 28, 2022 48:38


Discover the unique Temple Katz SOM program [Show Summary] The Temple Katz School of Medicine distinguishes itself with two campuses, a Narrative Medicine Program, and deep ties to the local community. In this interview, Jacob Ufberg, Associate Dean of Admissions, shares everything applicants need to know to get accepted to Temple Katz.  Interview with Temple Katz School of Medicine Admissions Dean, Dr. Jacob W. Ufberg [Show Notes] Welcome to the 476th episode of Admissions Straight Talk. Thanks for tuning in.  The medical school application process is complex. Think of it like a structure that you're building with many elements and floors. Like any building, it requires a strong foundation. Accepted's free four-part video course, which takes less than half an hour to complete, lays out the foundation of an outstanding medical school application. Watch it today at medschoolessentials.com. Our special guest today is Dr. Jacob Ufberg, Associate Dean for Admissions at Temple University's Lewis Katz School of Medicine and Director of the Emergency Medicine Residency Program. He completed his bachelor's degree at the University of Pennsylvania, then he earned his MD at the Lewis Katz School of Medicine and did his residency in Emergency Medicine at The Medical College of Pennsylvania in Philadelphia. He returned to Temple University's Katz School of Medicine after completing his residency and has since become Associate Dean of Admissions, Interim Assistant Dean of Career Advising, a Professor of Emergency Medicine, and an Emergency Medicine Residency Program Director. I'd say he's a little bit busy.  Can you give us an overview of Temple Katz's approach to medical education, focusing on its more distinctive aspects? [1:58] At Temple, we teach our clinical medicine and basic science interwoven together with our clinical faculty and basic science faculty integrated together into our pre-clerkship curriculum over the first year and three quarters. That can provide some clinical perspective for the basic science that the students are learning. We do a good deal of small group and case-based learning, and we have a strong focus on integrating the learning of safety, quality, social and structural determinants of health, disparities in health, and medical ethics. We have a wonderful simulation center here. We use simulation and standardized patients quite a bit in the pre-clerkship years for clinical correlation. We have a curriculum that allows for a lot of early and frequent clinical experience. We have two campuses, one here in North Philadelphia and one in Bethlehem, Pennsylvania at the St. Luke's University Health System. They both provide really wonderful clinical learning opportunities for the students. One of the great things is that the students have an opportunity to cross over from one campus to the other for some of their clinical learning opportunities over the years. Is there a different focus between the two different campuses? [3:37] I wouldn't say that there's a different focus. We are very well-aligned in how we teach, what we teach, and the experiences that the students have. There is a size difference. The campus here in North Philadelphia has 180 students per year and there are 40 students per year at the St. Luke's campus. Each offers unique benefits. The students up here love the urban setting. The students down on the St. Luke's campus love living at a slightly more relaxed space. They have a smaller learning group that provides the opportunity to really mesh together, grow together over the years. Can you describe the Narrative Medicine Program? Is that for all students or is it an elective? [5:36] Any student has an opportunity to participate in the Narrative Medicine Program. Narrative medicine is kind of a newer thing, and it really lives at the intersection of science and medicine and the humanities. It's about storytelling. It's listening to patients and their families,

What Next | Daily News and Analysis
Does Gun Violence Need an Emmett Till Moment?

What Next | Daily News and Analysis

Play Episode Listen Later Jun 13, 2022 24:06 Very Popular


To the people who deal with the reality of bullet wounds, the aftermath of shootings aren't so abstract. If politicians and the public had to see what military weaponry actually does to the body, would that change the conversation around gun control? Guest: Dr. Amy Goldberg, interim dean of the Lewis Katz School of Medicine and surgeon-in-chief at the Temple University Health System. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you'll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Slate Daily Feed
What Next: Does Gun Violence Need an Emmett Till Moment?

Slate Daily Feed

Play Episode Listen Later Jun 13, 2022 24:06 Very Popular


To the people who deal with the reality of bullet wounds, the aftermath of shootings aren't so abstract. If politicians and the public had to see what military weaponry actually does to the body, would that change the conversation around gun control? Guest: Dr. Amy Goldberg, interim dean of the Lewis Katz School of Medicine and surgeon-in-chief at the Temple University Health System. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you'll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

Trumpcast
What Next: Does Gun Violence Need an Emmett Till Moment?

Trumpcast

Play Episode Listen Later Jun 13, 2022 24:06


To the people who deal with the reality of bullet wounds, the aftermath of shootings aren't so abstract. If politicians and the public had to see what military weaponry actually does to the body, would that change the conversation around gun control? Guest: Dr. Amy Goldberg, interim dean of the Lewis Katz School of Medicine and surgeon-in-chief at the Temple University Health System. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you'll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Kinked Wire
JVIR audio abstracts: June 2022

The Kinked Wire

Play Episode Listen Later May 26, 2022 15:25


This recording provides audio versions of featured abstracts from the June 2022  Journal of Vascular and Interventional Radiology (JVIR), the Society of Interventional Radiology's flagship publication. Abstracts read in this episode include:Outcomes of Stroke Thrombectomy Performed by Interventional Radiologists versus Neurointerventional Physicians, Sacks et al.  READ Effects of the Cerebral Aneurysm Treatment Method on Coil Packing Density and Its Relationship with the Ostium Area, Kesim et al.  READ Covered Stents for Treatment of Visceral Artery Aneurysms: A Multicenter Study, Qiu et al. READTransarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis, Schartz et al.  READ Utility of the RENAL Nephrometry Scoring System in Predicting Complications and Outcomes of Percutaneous Microwave Ablation of Renal Tumors, Jayet et al.  READ Treatment of Severe Renal Artery Stenosis with Acute Kidney Injury Requiring Hemodialysis by Percutaneous Transluminal Renal Angioplasty and Stent Implantation, Nabil et al.  READ JVIR and SIR thank all those who helped record this episode:Host: Sanna Herwald, MD, PhDAudio editor: Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaJ.C. Panagides, Harvard Medical School, Massachusetts Karam Musaitif, Idaho College of Osteopathic MedicineAyman Mustafa, State University of New York at BuffaloElana Benishay, Northwestern University Feinberg School of Medicine, Illinois Anushree Rai, Chhattisgarh Institute of Medical Sciences in Bilaspur, IndiaShunn Theingi, Lewis Katz School of Medicine at Temple University, Pennsylvania ©  Society of Interventional Radiology.Support the show

Philadelphia Community Podcast
What's Going On: Lifeguard Shortage (Where to Apply) Stroke Prevention, "Replacement Theory"

Philadelphia Community Podcast

Play Episode Listen Later May 20, 2022 29:57


Democratic US Senatorial Candidate John Fetterman was hit with a stroke and atrial fibrillation on the eve of the PA Primary. What better time to raise our awareness about stroke during May Stroke Awareness Month? I speak to Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor at the Lewis Katz School of Medicine at Temple University about warning signs of stroke, treatment and prevention.https://www.heart.org/en/about-us/heart-attack-and-stroke-symptomsThere is dire need for lifeguards in order to open Philadelphia's public pools. I speak to Philadelphia's Commissioner of Parks and Recreation, Kathryn, Ott Lovell about the requirements and where to apply.www.phila.gov/lifeguardsThe terrible, racially motivated massacre in Buffalo has its roots in a fringe conspiracy theory called replacement theory. Except it's not so fringe anymore thanks to among other, commentators like Fox's Tucker Carlson. I speak to Amy Spitalnick, Executive Director of Integrity First for America, a non-partisan, nonprofit organization that won a lawsuit against White Supremacist Leaders and groups for planning racially motivated violence.https://www.integrityfirstforamerica.org/

Philadelphia Community Podcast
Insight Pt. 2: Lifeguard Shortage (Where to Apply) Stroke Prevention, "Replacement Theory"

Philadelphia Community Podcast

Play Episode Listen Later May 20, 2022 30:43


Democratic US Senatorial Candidate John Fetterman was hit with a stroke and atrial fibrillation on the eve of the PA Primary. What better time to raise our awareness about stroke during May Stroke Awareness Month? I speak to Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor at the Lewis Katz School of Medicine at Temple University about warning signs of stroke, treatment and prevention.https://www.heart.org/en/about-us/heart-attack-and-stroke-symptomsThere is dire need for lifeguards in order to open Philadelphia's public pools. I speak to Philadelphia's Commissioner of Parks and Recreation, Kathryn, Ott Lovell about the requirements and where to apply.www.phila.gov/lifeguardsThe terrible, racially motivated massacre in Buffalo has its roots in a fringe conspiracy theory called replacement theory. Except it's not so fringe anymore thanks to among other, commentators like Fox's Tucker Carlson. I speak to Amy Spitalnick, Executive Director of Integrity First for America, a non-partisan, nonprofit organization that won a lawsuit against White Supremacist Leaders and groups for planning racially motivated violence.https://www.integrityfirstforamerica.org/

Brawn Body Health and Fitness Podcast
Dr. James Rory Tucker – Undersea Medicine, Health and Fitness Considerations in Diving, and MORE!

Brawn Body Health and Fitness Podcast

Play Episode Listen Later Apr 13, 2022 53:43


In this episode of the Brawn Body Health and Fitness Podcast, Dan is joined by Dr. James Rory Tucker to discuss undersea medicine, specifically scuba diving and free diving. The two discuss a variety of subtopics within these areas, including the Mammalian Dive Reflex, cardiovascular considerations for diving, temperature considerations, and MORE! Dr. James Rory Tucker is an Assistant Professor, Clinical Family & Community Medicine, in the Lewis Katz School of Medicine at Temple University. Dr. Tucker is interested in the studies of Musculoskeletal injuries, Exercise prescription, Athletic concussions, and medical assessment of scuba divers. Tucker received his MD from Drexel University of College of Medicine, his Fellowship as a Primary Care Sports Medicine at Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, and completed his residency in Family Medicine at The Reading Hospital and Medical Center, Reading, PA. Dr. Tucker is board certified in family medicine and sports medicine. For more on Dr. Tucker, you can click here: https://www.templehealth.org/doctors/james-rory-tucker To keep up to date with everything we are currently doing on the podcast, be sure to subscribe and follow @brawnbody on social media! This episode is brought to you by CTM band recovery products - the EXACT soft tissue recovery technology used by Dan. CTM Band was founded by Dr. Kyle Bowling, a sports medicine practitioner who treats professional athletes (and was a guest on the Brawn Body Podcast!). You can check out their website here: https://ctm.band/collections/ctm-band ... while you're there, be sure to use the coupon code "BRAWN10" for 10% off! This episode is also brought to you by Ice shaker! Use our affiliate link to help support future podcast episodes and development by clicking here: https://www.iceshaker.com?sca_ref=1520881.zOJLysQzKe Make sure you SHARE this episode with a friend who could benefit from the information we shared! Check out everything we do, including blog posts, fitness programs, and more by clicking here: https://linktr.ee/brawnbodytraining Liked this episode? Leave a 5-star review on your favorite podcast platform! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/daniel-braun/message Support this podcast: https://anchor.fm/daniel-braun/support

Breathe Easy
Interventional Pulmonology Career Pathways (Thoracic Oncology Assembly): Starting Out and Finding an IP Job

Breathe Easy

Play Episode Listen Later Mar 29, 2022 24:10


Access ATS 2022 On-Demand Highlights Starting May 25.GuestDr. Osheen AbramianAssistant Program Director, Interventional Pulmonology FellowshipAssistant Professor of Medicine Cooper Medical School of Rowan UniversityHostDr. Mark Weir M.B Ch.B Assistant Professor Thoracic Medicine at Lewis Katz School of MedicineTemple University

Breathe Easy
Interventional Pulmonology Career Pathways (Thoracic Oncology Assembly): IP as a Pathway to Leadership

Breathe Easy

Play Episode Listen Later Mar 22, 2022 28:33


Access ATS 2022 On-Demand Highlights Starting May 25.Guest  Dr. Daniel Sterman MD FCCP, ATSF, DAABIP. The Thomas & Suzanne Murphy Professor of Pulmonary & Critical Care MedicineDepartments of Medicine and Cardiothoracic Surgery Director, Division of Pulmonary, Critical Care & Sleep MedicineDirector, Multidisciplinary Pulmonary Oncology ProgramPrincipal Investigator, NYU Pulmonary Oncology Research Team (NYU PORT)NYU Grossman School of Medicine/ NYU Langone HealthHost Dr. Mark Weir M.B Ch.B Assistant Professor Thoracic Medicine at Lewis Katz School of Medicine Temple University

The Healthcare Education Transformation Podcast
Life Coaching for Women Physicians w/ Drs Ali & Mark Novitsky

The Healthcare Education Transformation Podcast

Play Episode Listen Later Jan 31, 2022 44:24


In this episode, we are joined by Drs Ali and Mark Novitsky. From MDs to health, fitness, mindset and life coaches for women physicians. They went from working in a broken healthcare system to starting a side hustle and side gig that turned into a full time gig that leaves them happy and fulfilled.   Biography:   Ali's Bio: Ali Novitsky, MD is the CEO and founder of Life Coaching for Women Physicians www.lifecoachingforwomenphysicians.com.  She is Triple board certified in Obesity Medicine, Pediatrics, and Neonatology.  She is a certified Life Coach,  National Speaker, Blogger, and Host of The Podcast “Life Coaching for Women Physicians”.  Ali attended Temple University School of Medicine and completed her Pediatric residency and Neonatal Fellowship at Thomas Jefferson/AI duPont Hospital for Children.  She completed her coach training at The Life Coach School. Ali helps women physicians achieve optimal health by optimizing their unique potential with simple strategies backed by science.  Ali offers two group coaching programs, GOALS Society and her CME program, Transform.  Ali is married to her med school sweetheart, Mark, who is a child and adolescent psychiatrist.  Together, they are raising two strong daughters and one energetic puppy.   Web: www.lifecoachingforwomenphysicians.com Instagram: @alinovitskymd    Facebook: Ali Novitsky MD Itunes Podcast Link:  https://podcasts.apple.com/us/podcast/life-coaching-for-women-physicians/id1506931432 Spotify Podcast Link: https://open.spotify.com/show/1qGhl7yML5Y2O2iHyecFPt   Mark's Bio: Mark A. Novitsky Jr. MD is a Dual Board Certified Child and Adolescent Psychiatrist and Adult Psychiatrist and owns/operates NOVITSKY MD boutique mind doctors, where the team emphasizes the importance of therapy and a embraces a patient-centered mental health approach to optimizing an individual's well being. Dr. Mark is an adjunct faculty for Lewis Katz School of Medicine at Temple University's Department of Psychiatry. He was previously the Corporate Medical Director for one of Philadelphia's largest non-profit Child Mental Health Organizations. He is a graduate of The Beck Initiative, a joint collaboration between The Aaron T. Beck Center at The University of Pennsylvania and CBH/DBHIDS, for Cognitive Therapy and Research. For the last several years, he has had the privilege of working at Washington DC's premier psychiatry office, Potomac Psychiatry, as a child and adolescent psychiatrist, adult psychiatrist, and a forensic expert witness providing court testimony in the DC, Maryland, and Virginia region. Potomac Psychiatry has been featured as the Faces of Washington, in The Washingtonian Magazine. Dr. Mark grew up in the Philadelphia suburbs, received his undergraduate degree from Wake Forest University (where he roomed with none other than F. Scott Feel, and attended both medical school and psychiatry residency at Temple University School of Medicine (now Lewis Katz School of Medicine at Temple University). He served as Chief Resident in his third year of residency at Temple. He completed Child and Adolescent fellowship at Thomas Jefferson University, where he served as Chief Fellow. During his fellowship, Dr. Mark was awarded a research grant. He has several publications in peer-reviewed journals and has presented his research at the annual meetings of both the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP). In 2013, his Adherence in Pediatric Psychopharmacology-A Multi-dimensional Perspective and Approach was a docent selection of American Academy of Child and Adolescent Psychiatry. Dr. Mark has taught hundreds of medical students and residents, and most recently was the lead Child and Adolescent Pscyhiatrist in a non-profit public outreach campaign to Philadelphia schools teaching school administration, teachers, counselors, and parents about how to identify and address Depression, Anxiety, Substance abuse, and Bullying. More recently, he has joined forces with his wife's company, Life Coaching For Women Physicians, to expand her content with such Q&A seminars as “Did I Screw Up My Kid?”, “Beyond Coaching”, and “Exercising Intimacy”.   Web: novitskymd.com   The PT Hustle Website Schedule an Appointment with Kyle Rice HET LITE Tool Anywhere Healthcare (code: HET)  

Better Man Clinics Podcast
Better Stream: Robotic Simple Prostatectomy for the Treatment of BPH

Better Man Clinics Podcast

Play Episode Listen Later Jan 13, 2022 55:44


In this episode we discuss robotic simple prostatectomy for men with urinary symptoms due to an enlarged prostate (BPH).  In prior episodes, we have discussed several treatment options for BPH including medications and a variety of procedures.  But what if the medications don't work and the prostate is just too big to qualify for minimally invasive surgical procedures?  Fortunately, robotic simple prostatectomy has emerged as a potential option for men in this situation.  But, how does this procedure work?  What are the risks?  How long is the recovery?  And how successful is it in relieving urinary symptoms of BPH for the long haul.  To help us answer these questions, we are fortunate to be joined by Dr. Daniel Eun.  Dr. Eun is a professor of urology and director of the Robotic Urologic Surgery Clinical Fellowship Program at the Lewis Katz School of Medicine at Temple University.  He is also the chief of robotic surgery and the director of minimally invasive robotic urologic oncology and reconstructive surgery at Temple University Hospital.  Aside from performing over 1000 robotic surgical procedures, Dr Eun has also extensively published peer-reviewed journal articles, book chapters, and video teaching guides and travels nationally and internationally as an invited lecturer to present research and to train robotic surgeons.

The Cutaneous Connection
37: Helping and Relating to Patients of All Hair Types

The Cutaneous Connection

Play Episode Listen Later Jan 13, 2022 31:47


Managing editor of Dermatology Times, Mary Scoviak, is joined by Candrice Heath, MD, FAAP, FAAD a dermatologist and assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, to discuss relating to patients with textured hair.

Your Radio Doctor With Dr. Marianne T. Ritchie
Episode 100: New Year's Resolution #1: Quit Smoking & Vaping

Your Radio Doctor With Dr. Marianne T. Ritchie

Play Episode Listen Later Jan 10, 2022 40:47


​On January 9, 2022, as the first part of a three-part series on New Year's Resolutions, our host Dr. Marianne Ritchie was joined by Jamie L. Garfield, MD, a highly respected pulmonologist from the renowned Temple Lung Center, for a discussion about a common resolution - to quit smoking or vaping.Listen now to learn the risks associated with smoking and/or vaping. For example, the use of any tobacco product causes increased risks for multiple diseases including more than 12 cancers! Hear tips on how to make a plan to quit smoking, and where to find support and resources, such as the American Lung Association, that will help you stick to it!Dr. Garfield is an Associate Professor of Thoracic Medicine and Surgery and Core Clinical Educator for Medical Students at the Lewis Katz School of Medicine, and Core Clinical Faculty for the Internal Medicine Residency at Temple University Hospital.Your Real Champion: Food, Folks & FaithEach week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. For this week, Your Real Champion was was Chuck Montufar!Chuck and his wife Joe are very thankful parents! When their daughter Cara was 12, she was diagnosed with cancer in her thigh. After extensive surgery and chemotherapy, Cara grew to become a healthy woman with a four-year-old son of her own. Chuck and Joe have shown their gratitude by giving countless hours to "Make a Wish" and "Katie's Krusaders". They were also a force in establishing the Ronald McDonald House at Front and Erie to serve families of seriously ill children at St. Christopher's Hospital. 

OrthoClips Podcast Series
Keys to success with the Masquelet technique

OrthoClips Podcast Series

Play Episode Listen Later Jan 8, 2022 15:36


Interview with Dr. Benjamin Taylor, Fellowship Director of the Orthopaedic Trauma Fellowship at Grant Medical Center, Columbus Ohio, Associate Program Director for OhioHealth Orthopaedic Surgery Residency, and Associate Clinical Professor at Ohio University and Dr. David Galos, Assistant Professor of Orthopaedic Surgery and Sports Medicine at the Lewis Katz School of Medicine at Temple University. […]

The Visible Voices
Bob McNamara and Darin Wiggins: What Matters in Emergency Medicine

The Visible Voices

Play Episode Listen Later Jan 6, 2022 36:32


Robert McNamara, MD, FAAEM a Professor and Chair in the Department of Emergency Medicine and Lewis Katz School of Medicine at Temple University. He is the past president of the American Academy of Emergency Medicine and currently Chief Medical Officer, AAEM Physician Group. He received his medical degree from Jefferson Medical College in 1982 and then completed his residency in Emergency Medicine at the Medical College of Pennsylvania.  He stayed on as faculty at MCP and was the residency program director until he departed for Temple University School of Medicine in 1999.  At Temple, Dr. McNamara along with his faculty was successful in the creation of a full academic department of EM in 2001 and he currently serves as Chairman at Temple University Hospital, the busiest Level 1 Trauma center in the Delaware Valley.  His scholarly contributions include over 100 peer reviewed articles and abstracts and numerous textbook chapters.  He was involved in the first studies bringing intra-osseous infusion and magnesium therapy for asthma to attention of the EM community.  Nationally, Dr. McNamara is a leading figure in the specialty of Emergency Medicine.  He has been active in leadership roles within a number of medical societies but is best known for his achievements as a founding member of the American Academy of Emergency Medicine (AAEM).  Dr. McNamara served as AAEM's President from 1996 until 2002. Under his leadership the organization gained national and international stature while representing board certified emergency physicians.  In 2015, he became the Chief Medical Officer of the newly created AAEM Physician Group which seeks to preserve physician-owned practices in Emergency Medicine. Dr. McNamara currently serves as the Premier Open Coach of the US National Dragon Boat Team. Teams under his direction have won 135 medals at the World Championships. Dr. McNamara was born and raised in Philadelphia and currently resides in Lafayette Hill, PA. Follow Bob on twitter and LinkedIn Darin G Wiggins MD is the vice chair Department of Emergency Medicine Stony Brook Southampton Hospital. He is the chair of the physician leadership committee Stony Brook Southampton Hospital.

The Gary Null Show
The Gary Null Show - 01.06.22

The Gary Null Show

Play Episode Listen Later Jan 6, 2022 55:43


Access to integrative therapy associated with better breast cancer survival Bryn Mawr Hospital and IQVIA, Inc., December 29 2021. An article that appeared on December 18, 2021 in the Journal of Oncology reported improved breast cancer survival among patients who had access to integrative therapies, including nutrition consultations or programs, exercise consultations or programs, patient support groups or patient-survivor pairings, spiritual services, psycho-oncology support, massage therapy, meditation or mindfulness, yoga, acupuncture or acupressure, music or art therapy, Reiki or therapeutic healing touch, and tai chi or qi gong. (NEXT) Substantial weight loss can reduce risk of severe COVID-19 complications Successful weight-loss intervention before infection associated with 60% lower risk of severe disease in patients with obesity Cleveland Clinic, December 29, 2021 A Cleveland Clinic study shows that among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of developing severe complications from COVID-19 infection. The research was published in the journal JAMA Surgery. Numerous studies have established obesity as a major risk factor for developing serious illness from an infection of SARS-CoV-2, the virus that causes COVID-19. Obesity weakens the immune system, creates a chronic inflammatory state, and increases risk for cardiovascular disease, blood clots, and lung conditions. All of these conditions can complicate COVID-19. (NEXT) Trial finds Ginkgo biloba may help stroke survivors maintain cognitive function Nanjing University in China, January 2, 2022 Life Extension Update starts the New Year with fresh findings concerning a potential benefit for Ginkgo biloba in ischemic stroke survivors. The herb could help maintain the brain's command and control ability known as executive function, as well as aid in other areas at risk of decline among those who have experienced a stroke. On December 18, 2017, the journal Stroke & Vascular Neurology reported positive cognitive effects in association with supplementation with Ginkgo biloba among men and women who had recently experienced an ischemic stroke. Post-stroke cognitive decline has been found to affect approximately 30% of stroke survivors, and can be progressive. According to the authors  possible mechanisms for ginkgo's benefits in stroke patients include prevention of programmed cell death and increased cerebral blood flow. (NEXT) Doing less, achieving more: How the practice of wu-wei can boost athletes' performance  Nanyang Technological University (Singapore), January 4, 2022 When athletes experience the state of flow or are in the ‘zone', they sometimes describe the feeling as one of effortlessness. Although their exertions may feel effortless, what their bodies achieve in terms of performance can be extraordinary. In recent years, an increasing number of sport psychologists recommend that athletes practice mindfulness as part of their mental preparation for competing. Mindfulness aims to develop a non-judgemental awareness of the present moment, and can not only improve focus, but also promote that elusive state of flow. In a conceptual review published in KeAi's Asian Journal of Sport and Exercise Psychology, a group of researchers assert that the ancient Chinese wisdom of wu-wei, which can be understood as non-doing or non-striving, is a natural extension of mindfulness training for athletes. (NEXT) Researchers find one autoimmune disease could lead to another University of Colorado, January 4, 2022 Researchers at the University of Colorado Anschutz Medical Campus have discovered that having one kind of autoimmune disease can lead to another. The scientists serendipitously found that mice with antibody-induced rheumatoid arthritis in their joints went on to develop spinal lesions similar to those in axial spondyloarthritis (AxSpA) which causes fusion of the vertebrate and curvature, or bending, of the backbone. Our results suggest that one autoimmune disease, such as inflammatory arthritis, may also lead to a secondary autoimmune disease such as AxSpA," said the study's lead author Nirmal Banda, Ph.D., professor in the division of rheumatology at the University of Colorado School of Medicine. "This interesting disease association may be due to the binding of anti-collagen autoantibodies to the spine, or to some alteration of the immune system that requires further investigation." (NEXT) Canola oil in the diet accelerates brain damage and increases the risk of dementia Temple University January 3, 2022 Canola oil is one of the most popular vegetable oils in the world. However, many integrative healthcare providers are sounding the alarm about this seemingly harmless oil. And, as you already know, “popular” doesn't always mean it's healthy for us. For example, a new study out of the Lewis Katz School of Medicine at Temple University and published in the journal Scientific Reportshas linked canola oil with a decrease in memory and learning indicative of Alzheimer's disease – the most common form of dementia. It's also associated with triggering unwanted weight gain. In short, canola oil seems to be doing more harm than good, especially inside the brain. Canola oil actually increased the risk factors linked to Alzheimer's disease (GUEST) Tony Lyons Subject:  The Censorship of Bobby Kennedy's books (and other books), The Real Anthony Fauci Tony Lyons is the president and publisher of Skyhorse Publishing, a company that has published over 10,000 volumes and has made a name for itself by publishing highly controversial books on vaccine risks, autism and more recently books countering the official Covid-19 narrative. For years, Tony has fought against book censorship, including books by Woody Allen, Alan Dershowitz, and Phillip Roth's biography. He is the publisher of Robert Kennedy Jr's new book, The Real Anthony Fauci, which is currently the nation's bestselling and yet the most censored book in America.  Skyhorse's website is skyhorsepublishing.com

Life Coaching for Women Physicians
86. Restarting Your Relationship with Mark Novitsky, MD

Life Coaching for Women Physicians

Play Episode Listen Later Dec 8, 2021 30:36


Why do we always think we have to wait until New Year's to set a resolution or change something big in our lives? We don't! We can start right now. Dr. Mark Novitsky and I are talking about how to restart any area of your life by setting small, achievable goals.   Restart and Create New Opportunities By: Figuring out what areas of your life you want to restart Brainstorm what specifically you want to restart Write down how you will do that Create small, achievable goals  Do it! Don't wait for the perfect time, there isn't one!   About Mark Novitsky, MD Dr. Mark Novitsky is a Board Certified Child and Adolescent Psychiatrist and Board Certified Adult Psychiatrist.  Dr. Mark believes that effective work with children involves working closely with parents, schools, and other medical/mental health providers - to achieve a joint goal of optimizing a child's well-being.   His extensive clinical experience includes, but is not limited to: Attention Deficit Hyperactivity Disorder (ADHD) Mood Disorders Depressive disorder Bipolar disorder Anxiety Disorders and Obsessive-Compulsive Disorder (OCD) Childhood trauma/Post-traumatic stress disorder (PTSD) Oppositional Defiant Disorder and Conduct Disorder Autism Spectrum Disorder Substance Use Disorders Dr. Mark is an adjunct faculty for Lewis Katz School of Medicine at Temple University's Department of Psychiatry.  He was previously the Corporate Medical Director for one of Philadelphia's largest non-profit Child Mental Health Organizations.  He is a graduate of The Beck Initiative, a joint collaboration between The Aaron T. Beck Center at The University of Pennsylvania and CBH/DBHIDS, for Cognitive Therapy and Research.  For the last several years, he has had the privilege of working at Washington DC's premier psychiatry office, Potomac Psychiatry, as a child and adolescent psychiatrist, adult psychiatrist, and a forensic expert witness providing court testimony in the DC, Maryland, and Virginia region.  Potomac Psychiatry has been featured as the Faces of Washington, in The Washingtonian Magazine. Dr. Mark grew up in the Philadelphia suburbs, received his undergraduate degree from Wake Forest University, and attended both medical school and psychiatry residency at Temple University School of Medicine (now Lewis Katz School of Medicine at Temple University). He served as Chief Resident in his third year of residency at Temple.  He completed Child and Adolescent fellowship at Thomas Jefferson University, where he served as Chief Fellow.   During his fellowship, Dr. Mark was awarded a research grant.  He has several publications in peer-reviewed journals and has presented his research at the annual meetings of both the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP).  In 2013, his Adherence in Pediatric Psychopharmacology-A Multi-dimensional Perspective and Approach was a docent selection of the American Academy of Child and Adolescent Psychiatry. Dr. Mark has taught hundreds of medical students and residents, and most recently was the lead Child and Adolescent Psychiatrist in a non-profit public outreach campaign to Philadelphia schools through Michael's Giving HAND (Micahel P. Donatucci Foundation, Inc ), teaching school administration, teachers, counselors, and parents about how to identify and address Depression, Anxiety, Substance abuse, and Bullying.   When he's not working, Dr. Mark enjoys spending time with his family, walking around Longwood Gardens, checking out live music, and being outdoors with his Labradoodle.   It's Not Too Late! It's not too late to restart and rethink any area of your life that doesn't feel good! Dr. Mark says that we don't have to wait for the perfect opportunity to have a restart. We can create our own opportunities to improve our lives. One of the key aspects of restarting is to think of it as a new opportunity. What's worked before? What hasn't worked? Reevaluate and create your restart realistically in ways that work for you. We think it's really important to consistently check in with your partner. This applies outside of the restart planning, too! Getting a sense of where each other is in life and what their priorities are is such an essential part of building a healthy relationship.   Relationship Restarts I personally love doing these restarts with Dr. Mark. We can bounce ideas off with each other, ask opinions on what the other thinks we should prioritize, and have a partner to keep each other motivated. Your partner can also help you see how you can restart something by thinking in a new way. Restarts have to work for you, but sometimes you need to think totally outside your normal line of thinking.  Dr. Mark and I are figuring out all the areas of our lives we want to restart. Once we've done this, we brainstorm what we can restart and improve and how to do that. Remember, smaller goals are often better and lead to long-term happiness!   Homework for Women Physicians What areas of your life are you looking forward to restarting? What kind of changes do you want to make? Let me know in the comments on the episode page!   In This Episode  How to view your restart as a new opportunity [1:30] The importance of regularly checking in with your relationships [10:30] How to plan a restart with your partner [12:00] What happens when you look at restarting as thinking of something in a different way [18:15] Why you should figure out all your areas to restart and work on small goals for each of them [24:00]   Quotes “You don't have to wait until New Year's, that's so cliche. The restart can happen now.” [5:11] “Resetting by being willing to have the difficult conversations, by being willing to hold the boundaries so we can feel content because we're thinking we are holding the boundaries. Also, maybe leave some space to be spontaneous.” [14:48] “You can love what you do and own it, not have to change it, and still be there for your family.” [25:35]   Resources Mentioned Join G.O.A.L.S. Society Free for 30 Days Check out the full episode page here Find Life Coaching for Women Physicians Online Follow Dr. Ali Novitsky on Facebook | Instagram  Subscribe to Life Coaching for Women Physicians on Apple Podcasts Podcast production by the team at Counterweight Creative   Related Episodes Episode 84: Reevaluating Your Relationship with Mark Novitsky, MD Episode 83: What Are You Waiting For? Episode 81: Say "Yes" to Yourself

Your Radio Doctor With Dr. Marianne T. Ritchie

On Sunday, December 5, 2021, our host Dr. Marianne Ritchie was joined by Jamie L. Garfield, MD, a highly respected pulmonologist from the renowned Temple Lung Center, for a discussion about lung cancer; the #1 cause of cancer death in both men and women. In fact, lung cancer causes more deaths than breast, prostate, colorectal, and brain cancers combined.Listen to learn about prevention, the latest developments in screening, and the great work of the American Lung Association.Dr. Garfield is an Associate Professor of Thoracic Medicine and Surgery and Core Clinical Educator for Medical Students at the Lewis Katz School of Medicine, and Core Clinical Faculty for the Internal Medicine Residency at Temple University Hospital.​Your Real Champion: Take a Deep Breath​Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. For this week, Your Real Champion was Tina Moyer!

Life Coaching for Women Physicians
85. Reimagining Your Relationship with Mark Novitsky, MD

Life Coaching for Women Physicians

Play Episode Listen Later Dec 1, 2021 28:23


There is so much power in reimaging yourself and your life. Whether you think you can, or you think you can, you're right - so which do you want it to be? Dr. Mark Novitsky joins me to talk all about reimagining the different areas of your life.   The Key Areas to Reimagine Your Life Yourself & Your Priorities Your Relationship Your Parenting Style Your Career   About Mark Novitsky, MD Dr. Mark Novitsky is a Board Certified Child and Adolescent Psychiatrist and Board Certified Adult Psychiatrist.  Dr. Mark believes that effective work with children involves working closely with parents, schools, and other medical/mental health providers - to achieve a joint goal of optimizing a child's well-being.   His extensive clinical experience includes, but is not limited to: Attention Deficit Hyperactivity Disorder (ADHD) Mood Disorders Depressive disorder Bipolar disorder Anxiety Disorders and Obsessive-Compulsive Disorder (OCD) Childhood trauma/Post-traumatic stress disorder (PTSD) Oppositional Defiant Disorder and Conduct Disorder Autism Spectrum Disorder Substance Use Disorders Dr. Mark is an adjunct faculty for Lewis Katz School of Medicine at Temple University's Department of Psychiatry.  He was previously the Corporate Medical Director for one of Philadelphia's largest non-profit Child Mental Health Organizations.  He is a graduate of The Beck Initiative, a joint collaboration between The Aaron T. Beck Center at The University of Pennsylvania and CBH/DBHIDS, for Cognitive Therapy and Research.  For the last several years, he has had the privilege of working at Washington DC's premier psychiatry office, Potomac Psychiatry, as a child and adolescent psychiatrist, adult psychiatrist, and a forensic expert witness providing court testimony in the DC, Maryland, and Virginia region.  Potomac Psychiatry has been featured as the Faces of Washington, in The Washingtonian Magazine. Dr. Mark grew up in the Philadelphia suburbs, received his undergraduate degree from Wake Forest University, and attended both medical school and psychiatry residency at Temple University School of Medicine (now Lewis Katz School of Medicine at Temple University). He served as Chief Resident in his third year of residency at Temple.  He completed Child and Adolescent fellowship at Thomas Jefferson University, where he served as Chief Fellow.   During his fellowship, Dr. Mark was awarded a research grant.  He has several publications in peer-reviewed journals and has presented his research at the annual meetings of both the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP).  In 2013, his Adherence in Pediatric Psychopharmacology-A Multi-dimensional Perspective and Approach was a docent selection of the American Academy of Child and Adolescent Psychiatry. Dr. Mark has taught hundreds of medical students and residents, and most recently was the lead Child and Adolescent Psychiatrist in a non-profit public outreach campaign to Philadelphia schools through Michael's Giving HAND (Micahel P. Donatucci Foundation, Inc ), teaching school administration, teachers, counselors, and parents about how to identify and address Depression, Anxiety, Substance abuse, and Bullying.   When he's not working, Dr. Mark enjoys spending time with his family, walking around Longwood Gardens, checking out live music, and being outdoors with his Labradoodle.   The Power in Reimagining Your Life Dr. Mark joins me for part two of this series! In this episode, we're talking about reimagining your life. When you reimagine your life, your relationship, your career, your parenting style, or wherever you need to put that energy, you're opening yourself up to so many opportunities. Not only can it give you more space, reimagining these aspects can help you feel better. You might feel closer to your partner, as Dr. Mark and I do, you can feel like a better parent, and you can have more clarity over what you want in your career.   Reimagining Your Life is Exciting Plus, isn't the very act of reimagining your life exciting? You have all these options and possibilities in front of you and get to choose who you want to be and show up as. Mark and I especially enjoyed this process when we reimagined how we want to parent. One thing that really helped me and Mark with our relationship was taking The Love Languages quiz. By understanding what ways we both need to feel love and how each other express it, we're in a much better position to be better partners.  Finally, Mark and I talk about how important it is to set boundaries when we're reimagining the areas of our lives. It's all well and good to make changes in x, y, z areas, but if you're not setting firm boundaries, you might find yourself sliding into old habits.   Homework for Women Physicians How can you start to reimagine some of the areas in your life? Let me know in the comments on the episode page how you can start doing this today.   In This Episode  What can happen when you reimagine yourself [10:00] How reimaging your life can give you more space [14:30] How reimaging your parenting style can be exciting [20:15] How to increase the effort to improve your love language with your partner [23:00] The importance of setting boundaries when reimaging your roles [25:30]   Quotes “We're talking about relationships, but it starts with what you are bringing to the table.” [8:55] “I'm so detail-oriented that reimagining me is seeing more of the big picture. The reason why is because I want to create more space in my life.” [10:22] “Reimaging the parenting is investing in our family now, deciding what way we want to go with it, and it's exciting.” [20:11]   Resources Mentioned Check out The Love Language Quiz for Yourself Check out the full episode page here Find Life Coaching for Women Physicians Online Follow Dr. Ali Novitsky on Facebook | Instagram  Subscribe to Life Coaching for Women Physicians on Apple Podcasts Podcast production by the team at Counterweight Creative   Related Episodes Episode 66: Dr. Dena George on Editing Your Life Story Episode 83: What Are You Waiting For? Episode 81: Say "Yes" to Yourself

Life Coaching for Women Physicians
84. Reevaluating Your Relationship with Mark Novitsky, MD

Life Coaching for Women Physicians

Play Episode Listen Later Nov 24, 2021 29:55


Finding balance, support, and boundaries with your partner can be difficult, especially when you're spending near-constant time together. I'm joined by my husband, Dr. Mark Novitsky, to talk about re-evaluating our relationship. Setting goals and boundaries, making time and effort, and supporting each other is essential for a healthy, thriving, happy relationship.   Re-Evaluate your Relationship By: Scheduling regular check-ins for all the different hats you wear Supporting your partner when they need it Set and stick to realistic boundaries, even when it's hard Recognize the effort your partner makes   About Mark Novitsky, MD Dr. Mark Novitsky is a Board Certified Child and Adolescent Psychiatrist and Board Certified Adult Psychiatrist.  Dr. Mark believes that effective work with children involves working closely with parents, schools, and other medical/mental health providers - to achieve a joint goal of optimizing a child's well-being.   His extensive clinical experience includes, but is not limited to: Attention Deficit Hyperactivity Disorder (ADHD) Mood Disorders Depressive disorder Bipolar disorder Anxiety Disorders and Obsessive-Compulsive Disorder (OCD) Childhood trauma/Post-traumatic stress disorder (PTSD) Oppositional Defiant Disorder and Conduct Disorder Autism Spectrum Disorder Substance Use Disorders Dr. Mark is an adjunct faculty for Lewis Katz School of Medicine at Temple University's Department of Psychiatry.  He was previously the Corporate Medical Director for one of Philadelphia's largest non-profit Child Mental Health Organizations.  He is a graduate of The Beck Initiative, a joint collaboration between The Aaron T. Beck Center at The University of Pennsylvania and CBH/DBHIDS, for Cognitive Therapy and Research.  For the last several years, he has had the privilege of working at Washington DC's premier psychiatry office, Potomac Psychiatry, as a child and adolescent psychiatrist, adult psychiatrist, and a forensic expert witness providing court testimony in the DC, Maryland, and Virginia region.  Potomac Psychiatry has been featured as the Faces of Washington, in The Washingtonian Magazine. Dr. Mark grew up in the Philadelphia suburbs, received his undergraduate degree from Wake Forest University, and attended both medical school and psychiatry residency at Temple University School of Medicine (now Lewis Katz School of Medicine at Temple University). He served as Chief Resident in his third year of residency at Temple.  He completed Child and Adolescent fellowship at Thomas Jefferson University, where he served as Chief Fellow.   During his fellowship, Dr. Mark was awarded a research grant.  He has several publications in peer-reviewed journals and has presented his research at the annual meetings of both the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP).  In 2013, his Adherence in Pediatric Psychopharmacology-A Multi-dimensional Perspective and Approach was a docent selection of the American Academy of Child and Adolescent Psychiatry. Dr. Mark has taught hundreds of medical students and residents, and most recently was the lead Child and Adolescent Psychiatrist in a non-profit public outreach campaign to Philadelphia schools through Michael's Giving HAND (Micahel P. Donatucci Foundation, Inc ), teaching school administration, teachers, counselors, and parents about how to identify and address Depression, Anxiety, Substance abuse, and Bullying.   When he's not working, Dr. Mark enjoys spending time with his family, walking around Longwood Gardens, checking out live music, and being outdoors with his Labradoodle.   The Importance of Boundaries and Communication When the pandemic hit, Dr. Mark and I knew we had to sit down and re-evaluate our relationship and the hats we wore. Living and working in the same house proved to be more challenging than we'd initially expected. We both found ourselves pushing boundaries. It's still a work-in-progress, but Mark and I opened the conversations that needed to happen so we could get our relationship and happiness back. We knew we needed to establish our goals in our relationship and as parents, but first, we needed to figure out our individual goals. By setting our individual goals, we were able to fit them into our shared goals easier. What's worked for us is setting aside time to discuss each of the different hats we wear; for example, if we're on a walk, we dedicate one topic per lap. It's all about finding what works for you.   Support Your Partner, Especially When Things Are Hard One of the things we've learned over the last two years is how to support each other as parents, too. Even though we have different parenting styles, we can still show up and ‘tap-in' when we see the other struggling or needing a bit of extra alone time. When things get difficult, as they do, especially when spending close to 24 hours together, we've found that remembering what originally drew us to each other is helpful. Going back to those early roots can help a relationship stay alive and loving. Finally, it doesn't have to always be about the outcome. I've noticed how Mark is making more of an effort in many different areas. I'm so excited to see how our relationship together, as parents, and as business owners continues to grow and evolve.   Homework for Women Physicians Are you and your partner setting aside time to have the conversations you need to? Do you struggle to set boundaries with your partner? Let me know in the comments on the episode page how I can support you!   In This Episode  How to discuss your goals as a couple [7:00] Why it's not only okay but essential, to have individual goals in a relationship [12:30] The importance of supporting your partner as parents [15:00] Remember why you fell for your partner in the beginning [22:30] The importance of setting aside time to have specific conversations [27:00] Why the effort often matters more than the outcome [28:30]   Quotes “The conversation for us started with talking about our couple's goals. But, in order to get to those couple's goals, we needed to start with talking about our individual goals and what we're bringing to the table.” [6:55] “That individual goal really was more than that. I wanted to have the time with Ali, I wanted to be able to do these walks. Once I committed to that goal, I was able to find time, even in this current busy schedule, to achieve some of that.” [13:24] “How did we want to show up as parents? One of the things that we both agreed on was that we wanted to give them life experiences. We want to travel as much as we can, we want to do all those different types of things. When we have that bit to look forward to, it really reminds us of the parents that we do want to be. So when the little things happen, the feistiness or the dumbbells getting thrown, when the tap-outs are happening, we have a vision of how we want to show up as our best selves, as parents. Knowing that there will be different parenting styles amongst partners but it doesn't matter. You can still work those in and choose to support each other.” [17:36]   Resources Mentioned Check out the full episode page here Find Life Coaching for Women Physicians Online Follow Dr. Ali Novitsky on Facebook | Instagram  Subscribe to Life Coaching for Women Physicians on Apple Podcasts Podcast production by the team at Counterweight Creative   Related Episodes Episode 79: Do More of What Works  Episode 81: Say "Yes" to Yourself  Episode 77: Not Just One of The Guys

Help and Hope Happen Here
Lauren Bendesky will talk about her diagnosis and recovery from Stage 4 Neuroblastoma, her role with the St. Baldrick's Foundation, and her career plans involving Oncology as she is now a Medical Student.

Help and Hope Happen Here

Play Episode Listen Later Oct 21, 2021 48:51


Lauren Bendesky was diagnosed with Stage 4 Neuroblastoma when she was 14 years old in 2012.  This diagnosis is rare for a teenager as this form of Pediatric Brain Cancer is usually found in children much younger.Lauren will talk about her successful battle against Neuroblastoma and becoming an Honor Child for the St. Baldrick's Foundation when she was 16, followed by her becoming an Ambassador for St. Baldrick's. Lauren is now a medical student at the Lewis Katz School of Medicine at Temple University and is focusing on a career in Oncology .

OrthoClips Podcast Series
Improving transgender care in orthopaedics

OrthoClips Podcast Series

Play Episode Listen Later Oct 1, 2021 11:00


Dr. Corinna Franklin, Director of Sports Medicine at Shriners Hospital, Philadelphia and Associate Professor of Orthopaedic Surgery and Sports Medicine, Lewis Katz School of Medicine at Temple University discusses how we can improve transgender care in orthopaedics.

ResetMD
"Ways to Bring Your Best to Whatever You Do" with Dr. Darilyn Moyer

ResetMD

Play Episode Listen Later Sep 25, 2021 29:34


Darilyn V. Moyer, MD, FACP, FRCP, FIDSA is the Executive Vice President and Chief Executive Officer of the American College of Physicians (ACP). She has served on ACP's Board of Regents, which manages the business and affairs of ACP and is the main policy-making body of the College, chaired ACP's Board of Governors, and served as Governor of ACP's Pennsylvania Southeastern Chapter. She currently serves on the Board of Directors for the Council of Medical Subspecialty Societies and is the President, and also serves as the Chair of the Board of Directors of the Primary Care Collaborative. Prior to becoming ACP's EVP and CEO, Dr. Moyer was a Professor of Medicine, Executive Vice Chair for Education in the Department of Medicine, Internal Medicine Residency Program Director and Assistant Dean for Graduate Medical Education at Lewis Katz School of Medicine at Temple University. She was previously the Co-Faculty Advisor for the Temple University School of Medicine Internal Medicine Interest Group and for the Temple University School of Medicine Student Educating About Healthcare Policy Group. Dr. Moyer currently practices part time at the Temple University Internal Medicine Associates. Dr. Moyer received the Temple University School of Medicine Women in Medicine Mentoring Award in 2012. She is a member of Women of Impact and is the 2020 Recipient of the American Medical Women's Association Elizabeth Blackwell Award, as well as the recipient of the 2020 Lewis Katz School of Medicine at Temple University Alumni Achievement Award. We are excited to have a conversation with her during #WomenInMedicineMonth. In this episode we discuss her resets into medical education and then to advocacy with the ACP. She shares her thoughts on finding what you are meant to do in your career. She discusses what supports her wellness and gives advice for women in medicine. She ends with the mantra of "Bring your Best to Whatever You Do Everyday." Pearls of Wisdom: 1. Take Care of Yourself- in whatever way works for you. Know what Recharges you. 2. Reach Out to People to hear their story. Be Curious and Listen. 3. Create Community inside and outside of medicine. 4. Write Down and Examine your short and long-term goals.

Your Radio Doctor With Dr. Marianne T. Ritchie
Episode 80: Emergency Medicine

Your Radio Doctor With Dr. Marianne T. Ritchie

Play Episode Listen Later Aug 15, 2021 41:15


On August 15, 2021, our host Dr. Marianne Ritchie was joined by Megan Healy, MD, an Associate Professor from Temple University Hospital, which boasts the busiest Emergency Department in the city and evaluates up to 100,000 patients a year.Dr. Megan Healy is also an Associate Professor of Clinical Emergency Medicine and an Assistant Program Director for the Emergency Medicine Residency at Lewis Katz School of Medicine at Temple University.Listen now to learn when you should choose Urgent Care versus the Emergency Department. You'll also have a better understanding of what symptoms and signs need immediate attention. ​Your Real Champion: Two For The Road​Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. For this week, Your Real Champions were Sister Constance Touey, IHM and Sister Jeannette Lucey, IHM!Sister Constance and Sister Jeannette are nuns who spent 31 years at St Francis de Sales School in Philadelphia. They came in 1984 when the school was in disrepair and many students were refugees from around the world. Armed with great teaching skills, structure, and love, they transformed the failing school into a model of academic excellence. This past Spring, they spent several weeks working at the Southern border helping to care for unaccompanied boys ages 13-17 and refugee families. In their round trip, they logged over 14, 500 miles. These incredible women are both over 80 years old!

Into the Absurd with Tina Brock
EP 056: Dr. Lisa Grunberger: A Jewish Adopted Woman's Reckoning with Her Refugee Origins

Into the Absurd with Tina Brock

Play Episode Listen Later Aug 9, 2021 63:37


Lisa Grunberger is the author of three books: Yiddish Yoga: Ruthie's Adventures in Love, Loss and the Lotus Position (Harper Collins); Born Knowing (Finishing Line Press) and I am dirty (Moonstone Press, First Prize Winner). A Pushcart nominee and Temple University Professor, her work has appeared in a wide variety of publications including The New York Times, Hanging Loose Press, Crab Orchard Review, Mudfish, Krytyka Literacka, Bridges: A Jewish Feminist Journal, The Drunken Boat, Paroles du Jour, and The Mom Egg Review. Her play about motherhood, infertility, and assisted reproductive technologies, Almost Pregnant, is currently under artistic development at the Squeaky Bicycle Theatre company in NYC and is published by Smith Scripts. Her work has been translated into Russian, Yiddish, French, Slovenian and Hebrew. Her play Evidence or Moon Immigrants premiered in NYC's Manhattan Theatre Company in 2018. Her one-act play “Alexa Talks to Rebecca, or “I'm sorry there are some things I cannot do yet, and explaining why is one of them” won the Audience Choice Award when it was produced in The Squeaky Bicycle's Guts and Glory Playwriting Contest in 2021. Lisa teaches Narrative Medicine and Yoga and Writing at the Lewis Katz School of Medicine. When she's not being a mom, a professor and a poet, she teaches Yoga and Writing Workshops at The Healing Arts Center in Philadelphia. She is currently working on her memoir, Spit: A Jewish Adopted Woman's Reckoning with her Refugee Origins. Lisa earned her doctorate in Comparative Religion and American Cultural History from the University of Chicago Divinity School where she studied the fascist health politics of early twentieth century fitness guru Bernarr Macfadden and how the gym serves as our modern cathedral. She double majored in English and Religious Studies at the University of Rochester where she was a DJ who conducted one of the first national interviews on AIDS in 1985.~~~~~~~ To explore past episodes of Into the Absurd, visit our Facebook page:https://www.facebook.com/pg/IdiopathicRidiculopathyConsortium/videos/ORThe IRC's YouTube channel: https://www.youtube.com/playlist?list=PLj9sR3Pi7_igB845rllrtsLhtqYnuwDRvAnd while you're there, be sure to SUBSCRIBE, so you don't miss any future episodes.

Philadelphia Community Podcast
What's Going On: Gift of Life - National Donate Life Month. PECO Bill Assistance Programs

Philadelphia Community Podcast

Play Episode Listen Later Apr 16, 2021 30:02


I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you an excerpt of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/First - Pennsylvania has ended the moratorium on utility shutoffs and the pandemic has put a strain on many household's finances. There is help. I speak to Funmi Williamson, Senior Vice President at PECO's and Chief Customer who shares information on the many programs to provide bill relief. www.peco/billrelief.

Philadelphia Community Podcast
Gift of Life - National Donate Life Month FB Live Panel - Extended Version

Philadelphia Community Podcast

Play Episode Listen Later Apr 16, 2021 51:43


I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you the uncut edition of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/

Philadelphia Community Podcast
Insight Pt. 2: Innovative Job Training @ Philadelphia OIC, Gift of Life - National Donate Life Month

Philadelphia Community Podcast

Play Episode Listen Later Apr 16, 2021 30:35


I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you an excerpt of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/But first – jobs are coming back – are you ready? I speak with Philadelphia OIC President and CEO Judge Renée Cardwell Hughes about the job outlook post pandemic and the job training and academic programs preparing individuals for the evolving workforce.https://www.philaoic.org/

Surgery Sett
A Tribute to Dr. John Daly

Surgery Sett

Play Episode Listen Later Apr 1, 2021 34:22


A Tribute to Dr. John Daly Dr. John Daly, the dean of Temple University’s Lewis Katz School of Medicine, passed away on Friday, March 26, 2021 at the age of 73. Dr. Daly touched the lives of so many in and out of the world of surgery. In this tribute, Dr. Mezrich provides a window into his life through an interview he had with Dr. Daly a couple of years ago, as well as his own experiences with him. Our hearts go out to Dr. Daly’s family, and all affected by passing.

Circulation on the Run
Circulation March 16, 2021 Issue

Circulation on the Run

Play Episode Listen Later Mar 15, 2021 28:27


Dr. Carolyn Lam: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. We're your co-hosts, I'm Dr. Carolyn Lam, associate editor from the National Heart Center and Duke National University of Singapore. Dr. Greg Hundley: And I'm Dr. Greg Hundley, associate editor and director of the Pauley Heart Center, VCU Health in Richmond, Virginia. Well, Carolyn, this week's feature involves interleukin-6 and a phenome-wide association study. So we have a lot to look forward to, but before we do that, how about we grab a cup of coffee and jump into the other articles in this issue? I could start first because I've got to tell you about some results from the ODYSSEY outcomes trial. And Carolyn, this comes to us from Professor Gregory Schwartz at the University of Colorado School of Medicine. Well, Carolyn, this study pertains to LDL lowering. As you know, recent international guidelines have lowered the recommended target levels of LDL cholesterol for patients at very high risk for major cardiovascular events or MACE. Dr. Greg Hundley: However, uncertainty persists as to whether additional benefit results from achieving LDL-c levels below some of these conventional targets. Now inferences from prior analyses are limited because patients who achieve lower versus higher LDL-c on lipid lowering therapy differ in other characteristics prognostic for MACE, and because few achieved very, very low LDL-c levels. So to overcome these limitations, these authors performed a propensity score matching analysis of the ODYSSEY outcomes trial, which compared alirocumab with placebo in 18,924 patients with recent acute coronary syndrome receiving intensive or maximum tolerated statin treatment. Dr. Carolyn Lam: Sensible question, and what did they find? Dr. Greg Hundley: Well, Carolyn, the main finding of the study was that after accounting for differences in baseline characteristics and adherence, patients treated with alirocumab who achieved LDL-c levels less than 25 milligrams per deciliter did not appear to derive further reduction in the risk of MACE compared to those who achieved LDL-c levels of say 25 to 50 milligrams per deciliter. So, Carolyn, the take-home message is that recent international guidelines have lowered LDL-c goals for patients at very high risk for MACE to levels less than 55 milligrams per deciliter, and in some cases, maybe less than 40 milligrams per deciliter. However, any potential benefit of achieving LDL-c levels significantly below these goals to those very low, less than 25 really remains uncertain. Dr. Carolyn Lam: Very interesting. Thanks Greg. Well, my paper is about the HOST-REDUCE-POLYTECH-ACS trial. Got your attention? All right. I'll tell you what it is. It's an investigator-initiated, randomized, open-label, adjudicator-blinded, multicenter, non-inferiority trial, which compared the efficacy and safety of durable polymer versus biodegradable polymer, drug-eluting stents. And these investigators led by Kyung Woo Park from Seoul National University Hospital looked at 3,413 patients with acute coronary syndrome. At 12 months, the primary endpoint of patient oriented composite outcome, which was a composite of all-cause death, nonfatal myocardial infarction, and any repeat revascularization, occurred in 5.2% of the durable polymer group and 6.4% of the biodegradable polymer group. And so that met the non-inferiority P value of less than 0.01. the key secondary end points of device oriented composite outcome, which is a composite of cardiac death, target vessel MI, or target lesion revascularization occurred less frequency in the durable polymer versus biodegradable polymer groups, and this was mostly due to a reduction in target lesion revascularization. The spontaneous nonfatal MI and stent thrombosis rates were very low with no significant difference between the groups. Dr. Greg Hundley: Well, Carolyn, you know one of my favorite questions, so what's the take-home message here? Dr. Carolyn Lam: In patients with acute coronary syndrome receiving PCI durable polymer drug-eluting stents were non-inferior to biodegradable polymer drug alluding sense with regards to patient-oriented composite outcome at 12 months. I think that's the significant take-home message, and it's accompanied by an editorial where all this is discussed, and this editorial is by Doctors Byrne and Hanratty from Dublin. Dr. Greg Hundley: Very nice, Carolyn. Well, Carolyn, I am going to turn to the world of basic science and discuss phospho-lamin phosphorylation and how that may regulate vascular tone, blood pressure, and hypertension in both mice and men. And it comes to us from Dr. Michael Shattuck from King's College, London. So Carolyn, it's long been recognized that smooth muscle Na,K-ATPase modulates vascular tone and blood pressure. However, the role of its accessory protein phospho-lamin has not been characterized. So Carolyn, the aim of this study was to test the hypothesis that phospho-lamin phosphorylation regulates vascular tone in vitro, and this mechanism plays an important role in the modulation of vascular function and blood pressure in experimental models, both in vivo and in man. Dr. Carolyn Lam: Okay. So what did they find? Dr. Greg Hundley: Carolyn, these authors found that in aging wild type mice, phospho-lamin was hypo-phosphorylated, and this correlated with the development of aging induced essential hypertension. In human subjects, they identified a non-synonymous coding variant, a single nucleotide polymorphism RS-61753924, which causes the substitution of R-70 C and phospho-lamin. The R-70 C mutation prevented phospho-lamin phosphorylation at searing 68. This variance rare Alleo was associated with increased blood pressure in middle-aged men. So Carolyn, taking together these translational animal and human studies demonstrate the importance of phospho-lamin phosphorylation in the regulation of vascular tone and blood pressure and suggest a novel mechanism for aging-induced essential hypertension. Dr. Carolyn Lam: Interesting. And I suppose opening the door to translationally preventing this hypertension. Very interesting. Well from the next paper we switch to cardiac troponins, and you know these are the cornerstone of diagnosing acute myocardial infarction. But have you ever wondered, what is the duration of ischemia necessary to induce a measurable release of the cardiac troponins, or the very early release kinetics of cardiac troponins following an ischemic event? Well, this study is the first to report the early release kinetics of cardiac troponin concentrations, following different durations of experimental coronary balloon occlusion in humans. Dr. Greg Hundley: Ah, Carolyn. So how did they do this? Dr. Carolyn Lam: So 34 patients with N geographically normal coronary arteries were randomized into four groups with different durations of induced myocardial ischemia from zero to 30, 60, 90 seconds. Ischemia was induced by inflating a balloon in the left anterior descending artery between the first and second diagonal branch. Blood was collected prior to balloon inflation and every 15 minutes for the first three hours and every 30 minutes for the next three hours. Cool, huh? Dr. Greg Hundley: Yeah. So did any of the patients suffer complications? Dr. Carolyn Lam: So the first thing to report is none of the patients had any complications, but what they found, and this was from authors, Dr. Iverson from Copenhagen, Denmark and colleagues. This is what they found increased cardiac troponin concentrations were detected by all three high sensitivity assays, be they high sensitivity troponin T by the Roche assay, high sensitivity troponin I by the Siemens essay, or high sensitivity troponin I by the Abbot essay. All assays detected a cardiac troponin increase after only 30 seconds of ischemia. High sensitivity troponin I by Siemens rose faster and reached a higher peak. Copeptin levels did not significantly change. So these interesting findings are accompanied by an editorial by Christopher deFilippi and Nicholas Mills discussing how the findings challenged some of our assumptions and may help shape future care pathways and the classification of ACS. Dr. Greg Hundley: Carolyn, so more in the evolution of high sensitivity troponins. Well, I'm going to shift to my last article of the day, and it focuses on eccentric remodeling and ischemic cardiomyopathy, and comes to us from Professor Konstantinos Drosatos at the Lewis Katz School of Medicine at Temple University. So Carolyn, these authors have shown that cardiomyocyte Krüppel-like factor or (KLF)-5 regulates cardiac fatty acid oxidation, and as heart failure has been associated with altered fatty acid oxidation, they now investigated the role of cardiomyocyte (KLF)-5 in lipid metabolism and the pathophysiology of ischemic heart failure. Dr. Carolyn Lam: Wow, Greg. What did they show? Dr. Greg Hundley: Well, Carolyn, they found that (KLF)-5 is induced during the development of ischemic heart failure in humans and mice and stimulates ceramide biosynthesis. Genetic or pharmacological inhibition of (KLF)-5 in mice with myocardial infarction prevents ceramide accumulation, alleviates eccentric remodeling, and increases left ventricular ejection fraction. Thus, the authors suggest that (KLF)-5 may emerge as a novel therapeutic target for the treatment of ischemic heart failure. Well, Carolyn, we've got some other articles in the issue, and I'm just going to tell you quickly about an in-depth article entitled, “Cardiovascular Disease and Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options” that come to us From Dr. Marx, and then I'm going to turn it over to you. Dr. Carolyn Lam: Yes, we've got an exchange of letters between Doctors Grace and Mital regarding the article, “A Validated Model for A Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.” There's an ECG challenge by Dr. Peng on an irregular complex tachycardia. And there's this very interesting on-my-mind paper by Dr. Skolnik simply entitled, Gratitude. And I just have to tell you a bit about it, and I'm quoting from it now, “…having two surgeries for a large aortic aneurysm and aortic regurgitation, I am also left with an overwhelming sense of gratitude for living in the age in which I'm living. While some focus on what is wrong in the world, at least for today, my focus is on what is right.” Now, please read that paper. It's just such a beautiful piece. And, finally, there's a perspective piece by Dr. Sandhu entitled, “The Affordability of Guideline-Directed Medical Therapy, Cost Sharing, and How Cost Sharing is a Critical Barrier to Therapy Adoption.” Well, looks like it's a wrap. Greg, let's get on to our feature discussion, shall we? Dr. Greg Hundley: You bet. Well, listeners, we are now coming to our feature discussion today, and we're very fortunate to have with us today, Dr. Martin Dichgans and Dr. Marios Georgakis both from Munich, Germany. And we also have Dr. Svati Shah from Duke University, one of our associate editors. Welcome to you all. And I'll start with you Martin, could you explain to us a little bit of the background behind this study and what was the hypothesis that you wanted to test? Dr. Martin Dichgans: Yes, of course. We are interested in stroke, and more broadly, in cardiovascular disease, and inflammatory cytokines and inflammatory mechanisms in general play a major role in cardiovascular disease and particularly in arthrosclerosis, which connects a cardiac disease and stroke and also multiple other disorders. So that was our starting point. And we previously noted the importance of specific inflammatory cytokines in stroke, which is all primary area of research. We then quickly became aware of the central position of IL-6, which is downstream of IL-1β in the inflammatory cascade, and recognized not only that there's a lot of data on IL-6 in cardiovascular disease already, but that IL-6 actually is implicated in multiple inflammatory conditions, including autoimmune diseases, vascular, as I mentioned, and also metabolic disorders. And we noted that IL-6 receptor inhibition is already in use in some of these disorders, particularly in the treatment of autoimmune diseases, but not yet in use in cardiovascular disease. Dr. Martin Dichgans: So we asked ourselves whether there would be any repurposing potential, and also whether there would be an opportunity to explore the safety profile in its full width using genetic data because, and this I didn't mention, we have a background in genetics, a large interest in genetics, and you might have noticed that previously there has been a wealth of genetic data coming out, both on stroke, but also on cardiovascular disease in general. So also including other phenotypes, like for instance, and it has now become possible via a methodology called Mendelian randomization to utilize these genetic data and explore causal relationships between exposures such as IL-6 levels or specific cytokines and outcomes such as ordinary-after disease or stroke, and even go one further and explore the therapeutic potential, and also the full width phenotypes that could be relevant in such a scenario. So what we did is we took advantage of large scale genetic data from the UK biobank and data on specific outcomes available in the UK biobank to dive into the questions we were interested in. Dr. Greg Hundley: Martin, that was a wonderful explanation. So could you describe, what was the aim of your study? Dr. Martin Dichgans: In brief, the aim was to use large scale genetic data to explore the repurposing potential and safety profile of IL-6 receptor inhibition in the general population. Dr. Greg Hundley: Very nice. Describe your study design. Dr. Martin Dichgans: So the study population was the UK biobank, which is a population-based sample of, in this case, 340,000 unrelated individuals. And what we did is we performed the phenome-wide association study. So we looked across all available phenotypes that are systematically encoded in the UK biobank, and which included both clinical outcomes and biomarkers, in this case about 1,400 clinical outcomes and 360 or 70 biomarkers and endophenotype of human disease in this biobank. And again, explored relationships between IL-6 receptor inhibition and the effect on these outcomes. Dr. Greg Hundley: Very nice. Well, Marios, let's turn to you. Could you describe the results? What did you find? Dr. Marios Georgakis: Yes. Hello from my side as well. So, as Martin mentioned, we explored associations between genetically down-regulated IL-6 signaling and 1,400 clinical outcomes, as well as with 360 biomarkers in another, I would say hypothesis reapproach. So, following corrections from output testing, we found significant associations with genetically down-regulated IL-6 signaling activity with 16 clinical outcomes and 17 biomarkers. As we had shown in the past, genetically down-regulated IL-6 signaling activity was associated with several cardiovascular phenotypes, specifically atherosclerotic phenotypes, primarily including coronary artery disease manifestations, but also for example, abdominal aortic. Interestingly though, we also found a significant association with a lower risk of type two diabetes, as well as with a lower glycated hemoglobin, another finding that was consistent not only in the UK biobank, but also in two cohorts that we use for validation. So in the past, there have only been data from small observational studies and small case series in patients with rheumatoid arthritis supporting these findings, but to date, no data from large clinical trials. Dr. Marios Georgakis: Furthermore, we find significant associations between genetically down-regulated IL-6 signaling and higher total cholesterol, but also higher HDL cholesterol levels, but no association with LDL cholesterol. This further supports associations of IL-6 signaling downregulation with, let's say more favorable argument among the profile. Now, why is this important? This is a very interesting finding because previous clinical trials had suggested that IL_6 receptor inhibitors might lead to increases in total cholesterol levels, which would, of course, be an undesired side effect for people who'd ever envisioned using IL-6 receptor inhibitors in the context of lowering cardiovascular risk. Dr. Marios Georgakis: Here, however, we show, and our results support, that this increases primarily the results of the effects of IL-6 signaling bar down-regulation on HDL and not LDL levels. On the negative side, and finally, we found significant associations between genetically down-regulated IL-6 signaling and the number of potential side effects, particularly strong associations with bacterial infections, such as cellulitis and urinary tract infections, which is probably also related to the identifed association with the lower risk of neutropenia. So while these are well-described side effects of IL-6 signaling and condition in the context previous clinical trials, this, we believe, disagreement with our findings adds additional confidence to, let's say, the validity phenome-wide association state. Dr. Greg Hundley: Very nice Marios. Really appreciate this exciting work. And now we want to turn to our associate editor, Doctor Svati Shah. And Svati, you have many papers come across your desk, what attracted you to this paper? And then how do you put the results that these men have presented into context with other papers in this area of investigation? Dr. Svati Shah: Yeah. Great question, Greg, and thanks for having me. I thought this paper was really important, but I want to start at a broader level, and that's why it's attracted my attention is, I think genetics can not sort of inherently appeal to the broad Circulation reader. It can feel somewhat esoteric. We do these genome-wide association studies, these whole-exome association studies, and we find new genes and we're really excited about them as people who live in the genetic epidemiology realm. But when we think about the broader circulation readership and the broader cardiology readership, how does this really relate to how I take care of patients, and what might be important for me in my cardiovascular realm? And I think this paper really highlights the power of human genetics and how we really understand things that have clinical utility. Dr. Svati Shah: And let me just expand on that really briefly. And that is, in the human genetics realm, we can look at what we call human knockouts. We're not actually doing gene editing in humans, but looking at people who have loss of function variants. They're emulating a drug for example. And we also have PheWAS, which is a phenome-wide association study, where we say, "We're just going to look at lots of different clinical things and biomarkers and try to understand things that are associated." And then finally we have Mendelian randomization, which allows us at a very statistical level to really assess causality. We know there are things that are correlated with each other, but we don't necessarily know that they're causal, and this is a statistical way for us to potentially assess causality. I say that very carefully because it's a statistical way to do that. Dr. Svati Shah: And what's really cool about this paper is they combine PheWAS and Mendelian randomization, but with a very clinically important aspect. What are the potential good side effects, the on-target things that we want to try to address with these potential drugs, like tocilizumab, and what are potential side effects of these potential drugs. And in this case, because they combined PheWAS, they're able to look across all kinds of things. So the things that we already know about, they're not looking at a drug per se, but they're emulating a drug by looking at these genetic variants to say, "Okay. Well, we're going to look across all these different clinical factors." So it's not only things that have been evaluated in these clinical trials, but even just beyond that. And then the Mendelian randomization piece allows them to be able to say, again, statistically, are these causal. So if you antagonize these receptors, does it 'cause' these downstream effects. So, that's what was really cool to me about this paper. Is it really highlights the potential for human genetics in a very short term translational clinical potential. Dr. Greg Hundley: What a wonderful explanation for our listeners here. Well, let me ask each of you, Martin, Marios, and then Svati, what do you see as the next research endeavor in this space? Martin, you first. Dr. Martin Dichgans: And I completely agree with Svati that we have to utilize genetics in order to improve our means of treating patients, and I think that's obviously our aim here. And what this study shows, and let me just briefly also confirm what you said, we were intrigued by how the genetic data reflect what we see, for instance, in clinical trials. Just to expand a little bit on that aspect, the seven genetic instruments, which consisted of seven snips, single nucleotide polymorphism, when we looked at the effects of genetic lowering in this context on upstream and downstream, known upstream and downstream biomarkers of IL-6 signaling, this really very much matched what we know from clinical trials with tocilizumab so with pharmacologically lowering IL-6 signaling. Again, giving us confidence that it's informative and we will see with genetics what we are going to expect in the future in clinical trials. Dr. Martin Dichgans: So now getting to your point here and providing an answer, what we see as the next step, we should, for instance, combine the genetic data we have here with genetic data on other approaches to see whether, and maybe Marios can be more specific about this, whether by combining two different approaches, for instance, LDL lowering and targeting residual inflammatory risk, whether we could in future clinical trial provide additional benefits to high-risk patients with a cardiovascular disease. And I think that will be a very important area. Also, I think we should extend this approach to other inflammatory cytokines that have come up in Mendelian randomization analysis to explore their potential in future clinical trials. Dr. Greg Hundley: Marios? Dr. Marios Georgakis: Yeah. So just to add a little bit on Martin's summary, I would say here that now that we have established the efficacy of anti-inflammatory approaches in lowering cardiovascular risk, both with clinical trials, but also with showing genetic and clinical evidence, I think that the next step is first to identify the proper clinical scenario where anti-inflammatory approaches targeting IL-6 signaling would be used for reducing cardiovascular risk in order to design the proper clinical trials. And secondly, as Martin mentioned, to explore whether targeting IL-6 signaling would, one, pass additive benefits on Kruppel available approaches such as lipid-lowering approaches, and second, to see whether the risk-benefit balance of anti-inflammatory targeting IL-6 signaling would be acceptable in the clinical setting. Dr. Greg Hundley: And Svati. Dr. Svati Shah: Yeah. It's hard to follow up on those comments. I'll say, since I am very interested in diabetes and insulin resistance, the cholesterol story is fantastic, but I think the fact that they see effects on, again, statistical lowering of hemoglobin A1C and type two diabetes is fascinating to me. I would take it even a little step further. I think we need clinical trials. These data are very suggestive. It sort of flips the story almost. We've seen, even in some of the clinical trials of these drugs, that there are beneficial metabolic effects with regards to glucose, although some of the data are contradictory. So flipping it and saying, we know that inflammation is complex and we know that IL-6 has pro and anti-inflammatory roles in inflammation, and we know that diabetes with regards to inflammation is very complex, but maybe these drugs potentially are useful in type one and type two diabetes. So I think we need carefully designed clinical trials, potentially, to understand the role of blocking inflammation, and in particular IL-6 signaling, in patients who have diabetes. Dr. Greg Hundley: Excellent. Well, listeners, we want to thank Dr. Martin Dichgans, and Dr. Marios Jojakas, and our own associate editor, Dr. Svati Shah for bringing us this study incorporating phenome-wide association and Mendelian randomization to identify a relationship between down-regulated IL-6 signaling with subsequent clinical cardiovascular outcomes. Well, on behalf of Carolyn and myself, we want to wish you a great week and we will catch you next week on the run. This program is copyright of the American Heart Association 2021.  

ASRA News
A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised

ASRA News

Play Episode Listen Later Jan 13, 2021 13:53


"A Primer for Pain Physicians on Gadolinium-Based Contrast Agents: Caution Is Advised," by Zachary Pellis, BA, Lewis Katz School of Medicine, Philadelphia, Pennsylvania; Leonard DeRiggi, MD, Brighton Radiology Associates, Sewickley, Pennsylvania; Kim Shaftner, MD, JD, Fellow of the American College of Legal Medicine, Knott & Boyle, PLLC, Raleigh, North Carolina; David A. Provenzano, MD, Pain Diagnostics and Interventional Care, Sewickley, Pennsylvania. From ASRA News, November 2020. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.

The Medicine Mentors Podcast
Reverse Mentorship with Dr. Thomas Fekete

The Medicine Mentors Podcast

Play Episode Listen Later Oct 13, 2020 18:29


Thomas Fekete, MD, is the Thomas M. Durant Professor & Chair of the Department of Medicine at the Lewis Katz School of Medicine at Temple University. Dr. Fekete is a professor of Microbiology and Immunology. He is a member of Alpha Omega Alpha Medical Honor Society, a fellow and master of the American College of Physicians and Fellow of the Infectious Diseases Society of America. He serves as the Chair of the Board of the IDSA Foundation and Chair of the Board of College of Physicians of Philadelphia. He is the recipient of serveral teaching honors at Temple including the Lindback Award, Golden Apple Teaching Award, Russell and Pearl Moses Teaching Award, Outstanding Senior Educator Award, and Temple Great Teacher Award. There is such a thing as reverse mentorship. And today, Dr. Thomas Fekete teaches us how we can use what we don't want to guide us toward what we do. While we are in pursuit of top mentors to help guide us towards excellence and success, Dr. Fekete reminds us to pay attention to those we might not want to learn from, too. If we come across someone we feel is a bad role model or teacher, we should observe that. Take notes, study it, and self-reflect on why we don't want to follow that particular path. One day we may find ourselves in the position of being mentors and educators—and we can prevent mistakes and shortcomings by observing mentorship from all angles. Pearls of Wisdom: 1. It's important to forgive yourself. Don't aim for perfection, aim to find yourself. 2. Pay attention to ‘reverse mentorship'. Pay attention to who or what you don't like, and learn from that to see what you want to avoid. 3. Don't be afraid of making mistakes, being wrong is a gift. We learn more from mistakes than we do from being right all the time.

Becker’s Healthcare Podcast
Gerard Criner, MD, FACP, Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Becker’s Healthcare Podcast

Play Episode Listen Later Oct 12, 2020 24:14


This episode features Gerard Criner, MD, FACP, Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University. Here he discusses Temple Health's approach to the COVID-19 pandemic, addressing patient hesitancy, and their strategy to advancing lung cancer patient care with Ion and da Vinci platforms. This episode is sponsored by Intuitive. Intuitive is a global technology leader in minimally invasive care and a pioneer of robotic-assisted surgery.

Oncology Overdrive
Overcoming Imposter Phenomenon with Darilyn Moyer, MD

Oncology Overdrive

Play Episode Listen Later Sep 28, 2020 46:14


In this episode, Darilyn Moyer, MD, FACP, FRCP, FIDSA, shares how she overcame imposter syndrome to get to where she is today, and how she hopes the pandemic could systemically help right the wrongs currently faced by women and underrepresented groups in medicine. Intro :04 About Moyer :13 The interview 3:44 How did you get where you are now? 3:53 How did you get over your imposter syndrome? 9:12 “We cannot be what we cannot see” 11:15 Tell me about the jedi mindset; what’s the initiative and what does it mean to you? 11:48 Are you optimistic that we’re heading in the right direction? 17:39 The pandemic has shed light on inequities 19:37 With your background in ID, what are your thoughts on the pandemic? 25:45 “Medicine is an art and a science” 32:44 This being an election year, what’s your advice for voting? 37:12 Thank you for everything you and the ACP do 43:02 Moyer’s take-home message 44:00 How to find Moyer 45:27 Darilyn V. Moyer, MD, FACP, FRCP, FIDSA, is adjunct clinical professor of medicine at Lewis Katz School of Medicine at Temple University, and executive vice president and chief executive officer of American College of Physicians. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Moyer can be reached on Twitter at @DarilynMoyer and via email at dmoyer@acponline.org. Follow us on Twitter @HemOncToday @ShikhaJainMD Disclosures: Jain reports she is a paid freelance writer for Lippincott. Moyer reports no relevant financial disclosures.

CATALYST
The Business of Social Issues

CATALYST

Play Episode Listen Later Sep 21, 2020 19:23


How can we stop the gun violence epidemic? Temple University’s Center for Urban Bioethics, housed at the Lewis Katz School of Medicine, uses evidence-based intervention programs to detect conflicts, treat high-risk individuals and change norms in Philadelphia to prevent gun violence. The program has had success, but its leaders are keenly aware that sustainable funding is needed to ensure the programs' long-term success.   That’s why the center partnered with the Fox School of Business to think of gun violence as a business model problem and come up with a sustainable path to funding. In this episode, host Tiffany Sumner and TL Hill, managing director of Fox Management Consulting, discuss the project’s findings, how to measure success and what is happening with the CeaseFire project today.     Key Links TL Hill, PhD MBA students’ experiential learning bolsters testimony at state hearing on gun violence Philly’s gun violence solutions require state and city funding | Opinion Fox Management Consulting CeaseFire-Cure Violence ----- Follow us on Facebook LinkedIn Twitter Instagram -----

The JRHEUM Podcast
Q & A With the Author: Dr. Roberto Caricchio

The JRHEUM Podcast

Play Episode Listen Later Jun 25, 2020 22:18


Editor-in-Chief Dr. Earl Silverman speaks with Dr. Roberto Caricchio from Lewis Katz School of Medicine, Temple University about his and his co-author's letter Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together. Read the full article: DOI: https://doi.org/10.3899/jrheum.200744

AAEM/RSA Podcasts
Pearls & Pitfalls for New Graduates

AAEM/RSA Podcasts

Play Episode Listen Later May 28, 2020 21:04


In this episode, Brianna Beaver and Megan Healy, MD FAAEM discuss the pearls and pitfalls for new graduates. Ms. Beaver is a medical student at Western University of Health Sciences and the AAEM/RSA Western Regional Representative, and Dr. Healy is the Associate Professor and Clinical Emergency Medicine Assistant Program Director at Lewis Katz School of Medicine at Temple University, as well as the Immediate AAEM At large Member of Board of Directors; Immediate AAEM/RSA and YPS-AAEM Board of Directors; and Chair for the New Social EM and Population Health Interest Group.

AAEM/RSA Podcasts
Pearls & Pitfalls for New Graduates

AAEM/RSA Podcasts

Play Episode Listen Later May 27, 2020 21:04


Presented by Brianna Beaver, a medical student at Western University of Health Sciences and AAEM/RSA Western Regional Representative and Megan Healy, MD FAAEM the Associate Professor, Clinical Emergency Medicine Assistant Program Director at Lewis Katz School of Medicine at Temple University, as well as the Immediate AAEM At large Member of Board of Directors; Immediate AAEM/RSA and YPS-AAEM Board of Directors; and Chair for the New Social EM and Population Health Interest Group. Intro music by Akashic Records, Key to Success - Discover the Possibility from the album Corporate Presentation - Key to Success, powered by JAMENDO.

Your Radio Doctor With Dr. Marianne T. Ritchie
Episode 15: COPD, Lung Transplants & COVID-19

Your Radio Doctor With Dr. Marianne T. Ritchie

Play Episode Listen Later May 10, 2020 41:56


On May 10, 2020, our host Dr. Marianne Ritchie was joined by Gerard J. Criner, MD, FACP, FACCP for a discussion about COPD, Lung Transplants & COVID-19.Dr. Criner is the Director of the Temple Health Lung Center, and the Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University.Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. Your Real Champions of the week were Pat Gannon and Siobhan Knox a mother/daughter duo of nurses.

Your Radio Doctor With Dr. Marianne T. Ritchie
Episode 13: COVID-19 & Organ Transplants

Your Radio Doctor With Dr. Marianne T. Ritchie

Play Episode Listen Later Apr 26, 2020 44:57


On April 26, 2020, our host Dr. Marianne Ritchie was joined by Kartik V. Shenoy, MD and Aaron D. Mishkin, MD for a discussion on COVID-19 in transplant patients.Dr. Shenoy is an Associate Professor of Thoracic Medicine and Surgery and the Associate Program Director of the Pulmonary and Critical Care Fellowship at the Lewis Katz School of Medicine at Temple University.Dr. Mishnik is an Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University.Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. Your Real Champion of the week was MJ Austin!

Narratives of North Broad Podcast - Stories From Temple Health
#5: Dr. Ellen Tedaldi - HIV/AIDS Pioneer and Leader

Narratives of North Broad Podcast - Stories From Temple Health

Play Episode Listen Later Apr 22, 2020 39:40


Dr. Ellen Tedaldi is an icon at Temple University Hospital and the Lewis Katz School of Medicine. She is beloved by patients, students and colleagues alike. Dr. Tedaldi has been caring for AIDS and HIV patients since before the disease had a name, and she continues to care for her patients today, still making home visits even in a pandemic. We caught up with Dr. Tedaldi before the coronavirus pandemic swept the world and nation to talk about her life in medicine, and we think the interview is as relevant and interesting today as ever. Thanks for tuning into our latest podcast, Narratives of North Broad, Stories from Temple Health. This is Hank Davis, a medical student, joined by Michael Vitez, Director of Narrative Medicine at Temple. Now, Dr. Ellen Tedaldi...(Note: this episode was recorded on October 8, 2019)Instagram: @narrativesofnorthbroadTwitter: @NarrativesofNB

The Whole Health Cure
"Kellyn Foundation and Making Healthy Choice the Easy Choice" with Meagan L. Grega, MD

The Whole Health Cure

Play Episode Listen Later Feb 24, 2020 44:24


Meagan L. Grega, MD, is the Co-Founder and Chief Medical Officer of Kellyn Foundation (www.kellyn.org), a 501(c)3 non-profit dedicated to making the Healthy Choice the Easy Choice.  Kellyn provides school-based healthy lifestyle education and “Garden as a Classroom” programs; supports access to nutrient-dense produce via the Eat Real Food Mobile Market and Lehigh Valley Corner Store Initiative; engages participants in hands-on, plant-based cooking classes in community settings and offers intensive therapeutic lifestyle change interventions for individuals and families.  She is a summa cum laude graduate of Bucknell University with a B.S. in Biochemistry/Cell Biology and earned her MD degree from the University of Pennsylvania Medical School.Dr. Grega spent several years as a medical officer in the United States Navy, attaining the rank of Lieutenant Commander before resigning from active duty service. She has been a staff Family Physician at Hunterdon Medical Center, the Director of Women's Health Services at Lafayette College and is currently the Managing Director of Llantrisant Retreat and Wellness Center (www.llantrisantretreat.com), the home of Kellyn Foundation.  She is a member of the ACLM Speaker's Bureau and frequently lectures on the topics of Lifestyle Medicine at colleges, universities, hospital Grand Rounds, medical residency programs and community forums. Mentoring residents, medical, dietician and nursing students is one of her passions.  She is honored to serve as adjunct faculty for the St. Luke's University Health Network Anderson Campus Family Medicine and Internal Medicine Residency programs and as a faculty advisor for the Lewis Katz School of Medicine at Temple University/SLUHN medical student Lifestyle Medicine Interest Group (LMIG).  She has been a featured speaker at American College of Lifestyle Medicine Annual Conferences, is a member of the True Health Initiative Council of Directors and serves as a member of several national task force groups dedicated to the expansion of evidence-based lifestyle medicine services.  Dr. Grega is a member of the American Academy of Family Physicians, a Fellow of the American College of Lifestyle Medicine and is board certified in both Family Medicine and Lifestyle Medicine.Child/Family health in general, and the obesity epidemic in particular, are issues in which Dr. Grega has had a long-standing interest. She believes the benefits of regular exercise, adequate sleep, supportive social connections, healthy food choices and the art of balance are the keys to improving our children's future, as well as our own. Towards that end, she is committed to finding practical solutions that can be implemented by families and communities to strengthen each other physically, emotionally and spiritually.To learn more, please visit:Kellyn Website is www.kellyn.orgKellyn FB is www.facebook.com/kellynfoundationKellynTwitter: @kellynorgKellyn email is:  info@kellyn.orgInformation about the Lehigh Valley Lifestyle Medicine Symposium that will be held March 27-28, 2020 can be found at www.lvlifestylemedicine.org.  Listeners of this show can get a 10% discount for the registration fee for the Symposium.  To receive the discount please email info@kellyn.org to receive the promo code to be used during registration on the website. This podcast is brought to you by Emory Lifestyle Medicine & Wellness. To learn more about our work, please visithttps://bit.ly/EmoryLM

Narratives of North Broad Podcast - Stories From Temple Health
#1: Dr. Naomi Rosenberg - Emergency Medicine and Narrative Medicine

Narratives of North Broad Podcast - Stories From Temple Health

Play Episode Listen Later Jan 23, 2020 34:28


In this inaugural episode, Hank and Michael talk with Dr. Naomi Rosenberg. She is an emergency medicine physician at Temple University Hospital and assistant director of the Narrative Medicine program here at the Lewis Katz School of Medicine. We discuss her journey into medicine and why she chose emergency medicine. We also talk about an inevitable aspect of being a doctor -- delivering bad news. And we dive into a discussion of her amazing essay that for days was the best read story on the New York Times website, "How to Tell A Mother Her Child is Dead." We also discuss what Narrative Medicine means, and why she believes it is so valuable for physicians, patients, and students.(Note: this episode was recorded on July 29, 2019)Instagram: @narrativesofnorthbroadTwitter: @NarrativesofNB

Narratives of North Broad Podcast - Stories From Temple Health
#0: Introduction to the Narratives of North Broad Podcast

Narratives of North Broad Podcast - Stories From Temple Health

Play Episode Listen Later Jan 23, 2020 4:29


Welcome to the Narratives of North Broad Podcast! This brief introduction will give listeners a chance to meet co-hosts Hank Davis and Michael Vitez, and it will give a glimpse of what listeners can expect from episodes to come. Hank Davis is a first year medical student at the Lewis Katz School of Medicine at Temple University in Philadelphia. Michael Vitez is a Pulitzer Prize winning journalist who is now the Director of the Narrative Medicine program at the Lewis Katz School of Medicine in Philadelphia.Instagram: @narrativesofnorthbroadTwitter: @NarrativesofNB

Behind the White Coat: Failure and Percyverance
006-It gets better ft. Student Doctor Anita Wamakima

Behind the White Coat: Failure and Percyverance

Play Episode Listen Later Nov 9, 2019 47:58


Fourth year medical student Anita Wamakima details her journey in medicine and the obstacles she's faced along the way. She explains the challenges in dealing with depression in college, and acknowledges that at the time she had no idea what she was experiencing. While she sought help, she had difficulty finding the kind of therapy that worked for her. Still she was able to persevere and get into the Lewis Katz School of Medicine at Temple University. While Anita has found herself in a much better place mentally, her physical health took a turn in medical school when she had to have surgery to repair her heart. She explains that even in that moment, she was in a rush to deal with her medical school obligations and did not want to be "slowed" down. This sort of mindset is not uncommon in the field of medicine and one that she delves a little deeper into. With all of her experiences, she shares advice to current medical students and those who will be applying to medical school. Find out how she coped with all of her challenges and how she was able to #percyvere.

Cancer Buzz
Survivorship Care After Immunotherapy

Cancer Buzz

Play Episode Listen Later Sep 11, 2019 15:51


The side effects of immunotherapies for cancer can affect any body system—both during active treatment and long after treatment has ended—and ongoing education is needed for oncologists, patients, primary care providers, and other clinicians caring for patients post-treatment. On this episode of CANCER BUZZ, learn about the transition from immunotherapy into post-treatment survivorship, how it differs from chemotherapy, and why coordination and communication among providers, patients, and caregivers is essential. Guest: Regina Jacob, MD, MSCE, Assistant Professor, Section of General Internal Medicine, Lewis Katz School of Medicine at Temple University Related Content: “Managing Survivorship Care After Immunotherapy,” by Regina Jacob, MD, MSCE Planning for Survivorship After Checkpoint Inhibitors (webinar) Real-World Experiences in Immunotherapy Delivery, in the July/August 2017 issue of Oncology Issues "Moving Beyond Silos: Involving Non-Oncology Specialists in IO," by the ACCC Immuno-Oncology Institute Elevating Survivorship: Results from Two National Surveys, by the ACCC Immuno-Oncology Institute The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.

American Osteopathic College of Physical Medicine and Rehabilitation

Hear from doctor Reed C. Williams, MD, MBS. Assistant Professor, Physical Medicine and Rehabilitation, Lewis Katz School of Medicine at Temple University, on how to give yourself the best shot at landing the PM&R residency of your dreams and his experience in Sports Medicine.

Hills and Valleys
Ep 10: Future Healthcare Business Models with Dr. Gordon Morewood, MD, MBA, FASE

Hills and Valleys

Play Episode Listen Later Jul 10, 2019 52:20


Dr. Gordon Morewood currently serves as Chair and Professor of Clinical Anesthesiology at Lewis Katz School of Medicine at Temple University. His research interests include pulmonary hypertension in surgical patients, knowledge transfer in graduate medical education, and incentive systems for medical professionals. You can follow him on Twitter @GordonMorewood and be sure to read his guest blog on our website at bit.ly/healthcaremodel

The Curbsiders Internal Medicine Podcast
#148 Benign Prostatic Hyperplasia for the Internist

The Curbsiders Internal Medicine Podcast

Play Episode Listen Later Apr 29, 2019 62:23


This week we narrow in on the enlarging prostate and decipher the common issue of benign prostatic hyperplasia with Adam C. Reese MD, Associate Professor of Urology at the Lewis Katz School of Medicine at Temple University and Chief of Urologic Oncology at Temple University Hospital. Learn how to interpret the symptom profile for patients presenting with common urinary issues, what to feel for in the digital rectal exam, how to treat BPH, and when to refer. ACP members can visit https://acponline.org/curbsiders to claim free CME-MOC credit for this episode and show notes (goes live 0900 EST). See you at SGIM 2019! Find us in our red Curbsider’s t-shirts handing out Curbsiders and Kashlak stickers/patches at SGIM 2019 in Washington DC! We’ll be recording full length shows and daily recaps! Credits Written and produced by: Paul Williams MD Hosts: Paul Williams MD, Matthew Watto MD Images and infographics: Elena Gibson, Beth Garbitelli Show Notes: Elena Gibson, Beth Garbitelli Edited by: Matthew Watto MD, Chris Chiu MD Guest: Adam Reese MD Time Stamps 00:00 SGIM announcement 00:30 Disclaimer, intro and guest bio 03:20 Guest one liner, book recommendation, favorite failure and surgical M&M 10:56 Case of benign prostatic hyperplasia, defining terms and obstructive/voiding versus storage/irritative symptoms 16:11 IPSS score and evaluating symptoms 22:10 Digital rectal exam. Will this give any useful information? 26:55 Taking a history about BPH and some lifestyle modifications 29:20 Lab studies for urinary tract symptoms and interpreting PSA and free PSA 36:20 Initial therapy for BPH and managing patient expectations, alpha blocker side effects 39:25 Choice of agent and monitoring symptoms on therapy 42:25 Nonpharmacologic management of bladder complaints 45:10 Who and when to refer to urology 47:33 Counseling about use of 5 alpha reductase inhibitors, their side effects and is there a risk for high grade cancer? 52:35 Phosphodiesterase inhibitors for BPH symptoms 53:50 Urethral milking. NOT prostate milking 54:55 Desmopressin for nocturia 56:20 Take home points 59:03 Prostate volume and PSA 61:10 Outro Full show notes available at http://thecurbsiders.com/episode-list. Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com.

AAEM/RSA Podcasts
Unconscious Bias & Patient Care

AAEM/RSA Podcasts

Play Episode Listen Later Mar 28, 2019 31:56


Presented by Jessica Fujimoto, MD, a Chief Resident at Temple University and Vice President of RSA and Megan Healy, MD FAAEM, a past board member of AAEM, AAEM Women in Emergency Medicine Committee member, former Chair of the Marketing Task Force, Associate Professor of Emergency Medicine at Lewis Katz School of Medicine at Temple University, and Assistant Program Director for their EM Residency Program. Intro music by Akashic Records, Key to Success - Discover the Possibility from the album Corporate Presentation - Key to Success, powered by JAMENDO.

JDD Podcast
An Oldie but Multifaceted Goodie: Thalidomide in Dermatology

JDD Podcast

Play Episode Listen Later Jan 1, 2018 21:19


In this throwback edition of the JDD Podcast “Ask the Investigator,” host Adam Friedman speaks with Dr. Sylvia Hsu, Professor and Chair of Dermatology at the Lewis Katz School of...

Circulation on the Run
Circulation September 5, 2017 Issue

Circulation on the Run

Play Episode Listen Later Sep 5, 2017 20:47


Dr. Carolyn Lam:               Welcome to "Circulation On The Run", your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr. Carolyn Lam, associate editor from the National Heart Center and Duke National University of Singapore. Today's feature paper looks at the early use of N-Acetyl Cysteine with nitrate therapy in patients undergoing primary PCI for STEMI. More soon right after this week's summary of original articles.                                                 The first paper identifies a novel association between Phosphatidyl Choline Transfer Protein, or PCTP expression, in the blood, and death or myocardial infarction in patients with cardiovascular disease. Now, PCTP regulates intermembrane transfer for phosphatidyl choline. Platelet PCTP expression has been shown to be associated with increased platelet responses upon activation of protease-activated receptor four thrombin receptors. In today's paper, first authors Dr. Mao and Songdej, corresponding author Doctor Rao, and colleagues from the Temple University School of Medicine in Philadelphia used DNA protein binding studies and human erythroleukemia cells, as well as luciferase reporter studies to show that PCTP is a direct transcriptional target of RUNX1, a major hematopoietic transcription factor that regulates platelet production and function. Furthermore, in 587 patients with cardiovascular disease, the authors showed that PCTP expression in the blood correlated with RUNX1 expression and was independently associated with future death or myocardial infarction. Thus, regulation of PCTP by transcription factor RUNX1 may play a role in the pathogenesis of platelet-mediated cardiovascular events.                                                 The next paper provides molecular insights into cardiac fibrosis and shows that bone marrow cells are involved in cardiac fibrosis during pathological stress. Drs. Kishore, Verma and colleagues from Lewis Katz School of Medicine and Temple University of Philadelphia hypothesize that interleukin-10 inhibits pressure overload-induced homing of bone marrow fibroblast progenitor cells to the heart, and inhibits their trans-differentiation to myofibroblasts, thus attenuating cardiac fibrosis. To test this hypothesis, the authors used pressure-overload in wild-type and interleukin-10 knockout mice by transverse aortic constriction, and used chimeric mice to determine bone marrow origin. They further isolated fibroblast progenitor cells from mouse bone marrow for mechanistic studies.                                                 They found that, in addition to resident cardiac fibroblasts, bone marrow-derived fibroblasts significantly contributed to progression of pathological cardiac fibrosis, and that pliotropic antiinflammatory interleukin-10 inhibited the recruitment and trans-differentiation of bone marrow fibroblast progenitor cells in the pressure-overloaded myocardium. At a molecular level, they showed that interleukin-10 inhibited TGFβ SMAD2-3 signaling in activated bone marrow fibroblast progenitor cells. Furthermore, inhibition of TGFβ SMAD2-3 signaling mediated micro-RNA21 maturation was a novel mechanism by which interleukin-10 inhibited bone marrow progenitor cells-mediated cardiac fibrosis. Thus, selective inhibition of bone marrow cells homing to the heart and of fibrotic signaling using interleukin-10 or selective RNAs might inhibit the transition of physiological hypertrophy to heart failure, and may be a potential therapeutic target to treat or prevent the development of hypertrophic remodeling.                                                 The next study looks at the risk of major bleeding in patients receiving ticagrelor compared to Aspirin after a TIA or Acute Ischemic Stroke in the SOCRATES study. As a reminder, the SOCRATES trial was the first outcome study with ticagrelor in patients with Acute Ischemic Stroke or TIA, who were given ninety days of monotherapy with ticagrelor, 90 milligrams, twice daily and compared with those given aspirin 100 milligrams daily. The trial found that ticagrelor was not superior to aspirin in reducing the primary composite endpoint of stroke myocardial infarction or death. In today's study, Dr. Easton and colleagues from University of California San Francisco aimed to describe the bleeding profile of monotherapy with ticagrelor versus aspirin in this population of patients with Acute Ischemic Stroke and TIA, to characterize major bleeding based on the PLATO, TIMI and GUSTO bleeding definitions, and to identify factors associated with major bleeding.                                                 They found that PLATO major bleeds occurred in 0.5% of patients on ticagrelor and 0.6% of patients on aspirin. The most common locations of major bleeds were intracranial and gastrointestinal. Intracranial hemorrhage was reported in 12 patients, or 0.2%, on ticagrelor and 18 patients, or 0.3%, in aspirin. Independent of bleeding classification, PLATO, TIMI or GUSTO, the relative difference between treatments for major or severe bleedings was similar. However, non-major bleeds were more common on ticagrelor. Thus, this paper contributes important data on the bleeding profile of ticagrelor in patients with acute cerebral ischemia, provides some reassurance that there's no increased risk of major bleedings with ticagrelor compared to aspirin, including intracranial bleeds, however, a numerical increase in minor bleedings with ticagrelor.                                                 The next paper tells us that single 24-hour urine collections may be useful for estimation of average sodium intake in populations. However, for a reliable estimation of cardiovascular and renal risk, multiple 24-hour urine collections may be needed. First author, Dr. Olde Engberink, corresponding author, Dr. Vogt and colleagues from Academic Medical Center Amsterdam selected 574 adults with EGFR above 60, an outpatient 24-hour urine sample, and at least one collection during a seventeen year follow-up. Sodium intake was estimated using a single baseline collection, and the average of samples that were collected during a one, five, and fifteen year follow-up.                                                 They found that estimates of daily sodium intake changed more than 0.8 grams in half of the subjects when using multiple follow-up collections instead of a single baseline collection. The way of estimating sodium intake significantly affected the observed relationship between sodium intake and long-term outcome. Hazard ratios for cardiovascular and renal outcomes changed up to 85% when multiple follow-up 24-hour urine collections were used, instead of a single baseline collection. Thus, in summary, relative to a single baseline, the use of subsequent 24-hour urine samples resulted in different estimations of an individual's sodium intake, while population averages remained similar. This had significant consequences for the association between sodium intake and long-term cardiovascular and renal outcome.                                                 That wraps it up for your summaries this week. Now to our featured discussion.                                                 Today for our featured discussion, we are talking about approaches to cardio protection. Now, we all know that the mortality rates in STEMI has improved over the last few years, because we've gotten better at reperfusion therapy with primary PCI, as well as effective secondary prevention therapy. However, the incidents and severity of heart failure following STEMI has been rising and thus, cario-protective therapies are of great interest to prevent heart failure and improve overall clinical outcomes following STEMI, following primary PCI. Over the years, a number of cardio-protective therapies have been tried, but have either been unable to reduce MI size or improve clinical outcomes following STEMI, but in this week's journal, we have an exciting trial, very interestingly of two old cardio-protective therapies showing a lot of promise in this area. And to do discuss this, I am so pleased to have the corresponding author, Dr. John Beltrame from University of Adelaide in Australia, as well as associate editor from Brigham and Women's Hospital in Boston, Massachusetts, Dr. Laura Mauri.                                                 John, you know, in my introduction I said this is very interesting. You're actually combining two old therapies, N-acetylcysteine and nitroglycerin in your approach in this trial. Now, both these drugs have been around for a long time. Please share with us what led you to think that a combination would work, what made you test the combination, and what makes your trial different from the other reperfusion studies before. Dr. John Beltrame:           So, nitroglycerin, of course, has been utilized to treat myocardial infarctions for many years, has been shown to reduce the chest pain in that scenario, but little reward in perhaps reducing infarct size. And one of the main benefits of that people don't know is the vasodilation effect that it has on the coronary arteries, as well as reducing the wall stress. So, what we thought to combine it with N-acetylcysteine, which potentiates nitroglycerin effects, but also is a free radical scavenger. So therefore it would actually also work on reperfusion injuries. So these have a very synergistic effect, and therefore we expected to have good benefits.                                                 The ... because we're also looking at an anti-ischemic therapy with a reperfusion protective therapy, we wanted to introduce it as soon as possible. And so this drug was initiated in the emergency department as patients arrived, and then taken off to the cath lab where it was continued. We also began to ensure that we had adequate N-acetylcysteine, which I'll probably refer to as NHC from now on, as much on board as possible before we actually opened the artery. We gave high dose N-acetylcysteine at 20 milligrams in the first thirty minutes, and then at a slower rate for the next twenty-four hours. So for the first hour we gave it at 20 milligrams a minute, and then thereafter 10 milligrams a minute. And then, the actual study. We had patients randomized and double-blind placebo control trial, multiple sites here within South Australia with the primary endpoint being myocardial infarct size on early cardiac MRIs.                                                 So they got to see the opportunity to have a smaller sample size than many of the conventional infarct studies, and the key finding was in that early MRI, we saw an absolute 5% reduction in infarct size, which was an exciting find for us and this we expect to translate to a significant reduction in cardiovascular events and that's where I guess we're going in the future, is that we need to now undertake a study where we show that the combination of these two drugs also impacts on cardiac events. Dr. Carolyn Lam:               How beautifully summarized, John. And really, congratulations on such an impactful and elegantly done study. I like the way you highlight it, though. Basically, you gave this drug earlier than most other trials of reperfusion therapies, because you gave it even before the primary PCI procedure as most cardio-protective strategies were tried within the cath lab. Would that be accurate? Dr. John Beltrame:           Exactly right. So, whereas a number of the studies would take the patient with the STEMI to the cath lab, undertake the diagnostic angiogram and the diagnostic angiogram would then confirm that this was occluded, then they would introduce the cardio-protective agent and then proceed on to open up the artery. Whereas we had an opportunity for sort of ... at least twenty to thirty minutes before the artery was opened to actually have those drugs on board. And so, in a number of cases, we improved the patency of the vessel when we got to the diagnostic angiogram. So it's a two-point strategy, one anti-ischemic and one cardio-protective in terms of reperfusion injury. And we think that future trials in this area need to address both those conditions. Dr. Carolyn Lam:               I can think of no better person to comment on being able to do these trials and the future of these trials than Laura. Laura, what are your thoughts? Dr. Laura Mauri:               Thanks Carolyn. John, that was a great summary and I think you're really to be commended, because this is just such a challenging area to be doing trials in, but that's really what we need. And you know, most of the trials have focused on early procedure success for therapies that we currently use, rather than showing documented benefit in longer-term endpoints. But as you mentioned earlier, Carolyn, we really do still have patients who would benefit from therapies that may reduce infarct size. I think it's really remarkable, John, that your study was able to intervene early in the emergency room, as we know as clinicians that's not easy to do, not only to activate the quick pathways of care that we need for STEMI, but then on top of that to lay on a randomized trial, but I think it's incredibly important.                                                 What are you foreseeing as the challenges? As you think about your next steps in rolling this out to a ... potentially a larger trial and implementing such a study? Dr. John Beltrame:           As with many trials, it's ways of recruitment, because a study like this is not gonna be funded by industry, you need to be looking at ... here within Australia, be looking at government authorities to put in an application for funding and then, it's a matter of recruiting. That's one of challenges we came across in doing this particular study, and this relates particularly, I guess, to the MRI endpoint, is the number of patients that were claustrophobic and therefore we couldn't actually perform the cardiac MRI, and so your primary endpoint ... you missed out. And so again, there's going to be frustrations like that and a much larger trial, which will need to involve even more centers. But funding that's ... for much of the research, I guess, it will be the challenge, because we've got two agents as Carolyn mentioned in the beginning that have been around for a long time and are certainly unlikely to attract any industry funding. Dr. Carolyn Lam:               John, I have a question about the design as well. Of the current and maybe a future trial, because I'm left with the question, was it your early intervention? Was it the outcome you chose? Or was it one drug or the combination? And so, you did not do a factorial design in this trial. Are there plans to look at that, or do you the combination ... it's so obvious that two separate drugs don't need to be tested? Dr. John Beltrame:           Very good question. So, you're quite correct, we can't be absolutely confident in terms of the mechanism, because we had one opportunity, I guess, to do the study and so we wanted to keep a simplified design, and that's what we gave everyone; a background of nitroglycerin and then just randomized the N-acetylcysteine. But we think it's actually the combination of the two that makes the benefits, because as you would be aware, the synergistic benefits is that the N-acetylcysteine potentiates the effect of the nitrates, potentiates the vasodilating properties, potentiates it's anti-platelet properties also. And so we think it's a combination of the two. Dr. Laura Mauri:               John, it's interesting ... the use of the cardiac MRI endpoint, as we've all seen, it's being used more and more frequently, but at the same time, it's new for us, right? So you've raised some of the challenges and the practical execution of getting patients who can tolerate it, especially after an acute hospitalization. But the classical endpoint has been SPECT imaging as a surrogate endpoint for mortality in myocardial infarction. Of course, that's based on very large trials showing correlation, but the MRI should really give much better resolution, so I think that's really a very logical next step. But I think the more data that we get across multiple different trials, the better we can validate that endpoint and see how it might differ from the classical surrogate endpoints that we've had for myocardial infarction.                                                 Other than the efficiency of looking at MRIs, do you have other observations when you look at MRIs at endpoint compared with some of the traditional endpoints like SPECT? Dr. John Beltrame:           Not SPECT so much, but to follow on exactly what she was saying, we all also measured serum creatine kinase, so CK, values. And because of the larger spread of the data and therefore the need to have a larger sample size, although we certainly saw a trend of improvement in CKs as a marker of infarct size, we didn't achieve statistical significance, but with the MRI because we had more precise measurements, that gave us a smaller margin of error and therefore, we were able to see a difference between the two treatments. So certainly I think in the future, the MRI is certainly a very good way to evaluate agents in this particular area. Dr. Laura Mauri:               It's nice to see the consistency that you saw across the different endpoints. Dr. Carolyn Lam:               That's true, but I do have a question though, as an Echo cardiologist here, your three-month assessment of the ventricular remodeling, if I read it right, there was no change detected at three months. Would you like to comment on that? Dr. John Beltrame:           What we saw in terms of the infarct size, we still saw a difference. I think what you might be referring to, the infarct size was a little bit smaller, so that's just ... over time the we feel like the scar contracts down. But I'm not sure if you're also referring to the ... Dr. Carolyn Lam:               LV dimensions and injection fraction. Dr. John Beltrame:           The injection fraction's interesting, because when we looked at that ... because we found no difference in the injection fraction. Now, if you take a look at the actual values, they're almost normal and I think that says something to where we are in terms of the management of acute STEMIs, because we preserved the left ventricular function, because there were normal ejection fractions, so we couldn't make them better than what we had in placebo, so that is something to primary PCI, I think. Dr. Carolyn Lam:               That's a great answer. Thank you, John. And Laura? Dr. Laura Mauri:               John, your group is really to be commended for conducting such a high-quality trial in this very challenging area. We've been victims of our own success, I think, in this space because the mortality rates have obviously declined after MI, infarct size is on the decline with early reperfusion. Getting in there with attempted therapies is a race when you're also trying to achieve fast door-to-ballon times, but it's still an important area and one we can only address with careful, randomized trials with important therapies. So I want to congratulate you and your group, it's really a step in the right direction. Dr. Carolyn Lam:               You've been listening to "Circulation On The Run", thank you so much for joining us, and don't forget to tune in next week!  

AAEM/RSA Podcasts
Ultrasound Fellowships

AAEM/RSA Podcasts

Play Episode Listen Later Aug 11, 2017 18:13


2017-18 RSA Board Member and Liaison to the Education Committee, Jessica Fujimoto, MD speaks with Thomas Costantino, MD FAAEM, Professor of Emergency Medicine and Director of Ultrasound Fellowships at Lewis Katz School of Medicine at Temple University and Ryan Gibbons, MD FAAEM, Assistant Professor of Emergency Medicine at the Lewis Katz School of Medicine at Temple University and Founder and President of the AAEM Ultrasound Section. Drs. Fujimoto, Costantino, and Gibbons discuss ultrasound in emergency medicine and fellowships in ultrasound.

AAEM/RSA Podcasts
Ultrasound Fellowships

AAEM/RSA Podcasts

Play Episode Listen Later Aug 10, 2017 18:13


Presented by Jessica Fujimoto, MD, resident at Temple University Hospital and RSA board liaison to the Education Committee, Thomas Costantino, MD FAAEM, Professor of Emergency Medicine and Director of Ultrasound Fellowships at Lewis Katz School of Medicine at Temple University, and Ryan Gibbons, MD FAAEM, Assistant Professor of Emergency Medicine at the Lewis Katz School of Medicine at Temple University and Founder and President of the AAEM Ultrasound Section. Intro music by Akashic Records, Key to Success - Discover the Possibility from the album Corporate Presentation - Key to Success, powered by JAMENDO.

The World Transformed
CRISPR and the New Biotech Revolution

The World Transformed

Play Episode Listen Later May 10, 2017 31:00


Phil and Stephen discuss medical breakthroughs enabled by the new gene "word processor,' CRISPR CRISPR and the Dawn of the New Biotech Revolution CRISPR genome editing will transform biotechnology and our lives in the next decade making possible (and cheap*) all kinds of new cures, new crops, new livestock, new industrial processes, and new ways to manage the environmental commons. With regard to new cures, researchers at the Lewis Katz School of Medicine at Temple University and the University of Pittsburgh have just published results in which they used CRISPR to almost entirely eliminate HIV, the virus that causes AIDS, from living experimental animals. More Even though the virus starts as a simple infection, once it becomes part of a person’s chromosome, it essentially becomes a genetic disease. Imagine a world where, instead of removing her breasts, Angelina Jolie could instead have taken a dose of genes that snip away the BRCA2 genes that threatened her with cancer. That’s the difference between a treatment and a cure. WT 301-610

Off The Charts
Med students Tyler Rainer and Matthew Trifan tell us a story

Off The Charts

Play Episode Listen Later Mar 27, 2017 33:21


Andy listens to two young storytellers: Tyler Rainer and Matthew Trifan, fourth-year med students at the Lewis Katz School of Medicine at Temple University. Both prepared two moving stories from their Emergency Department rotations at Temple University Hospital, Philadelphia.

Circulation on the Run
Circulation July 12, 2016 Issue

Circulation on the Run

Play Episode Listen Later Jul 14, 2016 23:21


    Dr. Lam: Welcome to Circulation on the Run. Your weekly podcast summary and backstage pass to the Journal and it's editors. I'm Dr. Carolyn Lam, Associate Editor from the National Heart Center, and Duke National University of Singapore. Dr. Sanjay Kaul and Darren McGuire will be joining me in just a moment to share their perspectives on the EMPA-REG OUTCOME trials. Are the results with empagliflozin in diabetic patients at high risk, are they too good to be true. First, here are the highlights from five original papers in this week's issue. The first paper is from Dr. Gilboa, from the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention in Atlanta, Georgia, and Dr. Marelli from the McGill Adult Unit for congenital heart diseases in Montreal, Quebec, and colleagues. These authors recognize that because of advancements in care there has been a decline in mortality from congenital heart defects over the last several decades. However, there are still no current empirical data documenting the number of people living with congenital heart defects in the United States. These authors address this gap in knowledge by using prevalence data from Quebec, Canada, in the year 2010, as a foundation for a mathematical model, and estimated that in the United States in the year 2010, approximately 2.4 million people, including 1.4 million adults, and 1 million children were living with congenital heart defects. This estimate is significant, because it corresponds to a 63% increase in the estimated size of the adult population with congenital heart defects in the United States since the year 2000. This has significant implications for resource allocation for health services delivery that will need to account for this growing population of adults with congenital heart defects. The second paper is from first author Dr. Tabot, and corresponding author Dr. Liao, from the University of Chicago, and colleagues who aim to understand better the common complication of angiodysplasia leading to nonsurgical bleeding in patients with left ventricular assist devices. The authors studied 101 patients with heart failure, left ventricular assist devices, or orthotopic heart transplants. They found that compared to patients with heart failure, or transplant patients, patients with left ventricular assist devices had elevated serum levels, and endothelial expression of angiopoietin-2, which is a potent angiogenic mediator. Elevated levels of angiopoietin-2 in these patients increase angiogenesis in vitro, and were associated with bleeding events. Furthermore, they found that increased thrombin levels in left ventricular assist device patients were associated with elevated angiopoietin-2 levels. In aggregate, therefore, the results indicate that high levels of thrombin induced endothelial angiopoietin-2 expression, which may then contribute to angiodysplasia and non-surgical bleeding in patients with left ventricular assist devices. The clinical implications are that clinical studies angiopoietin-2, and factor 12 inhibitors may therefore be indicated to prevent nonsurgical bleeding in patients with left ventricular assist devices. The third paper is Dr. Gordon from Hasbro Children's Hospital in Rhode Island, and Dr. Kieran from the Dana Farber Cancer Institute in Boston, Massachusetts, and colleagues who addressed the Hutchinson Gilford Progeria Syndrome. An extremely rare, fatal segmental premature aging syndrome, where without specific treatment, death usually occurs at an average age of 14 1/2 years from an accelerated atherosclerosis. A PRIA single arm clinical trial has demonstrated that the protein farnesyltransferase inhibitor, Lonafarnib, ameliorates some aspects of cardiovascular and bone disease in this syndrome. The current trial sought to further disease outcomes by additionally inhibiting progerin prenylation using pravastatin and zoledronic acid on top of Lonafarnib in 37 participants with the Progeria syndrome. Results showed that the composite primary study outcome of increased rate weight gain and decreased carotid artery echodensity was achieved. Overall, participants experienced increased bone density, size, and structural properties. However, unlike the PRIA single arm Lonafarnib monotherapy trial, mean carotid-femoral pulse wave velocity and mean carotid artery adventitial echodensity were not improved. In addition, rates of carotid and femoral artery plaques and extraskeletal calcifications all increased. In summary, compared PRIA Lonafarnib monotherapy treatment, additional bone mineral density benefit, but likely no additional additional cardiovascular benefit was obtained with the addition of pravastatin and zoledronic acid. The authors concluded that since increased bone fracture is not a disease feature, the addition of a combination of statin and biphosphonate to Lonafarnib therapy is not recommended for clinical treatment of Progeria syndrome. However, it is reasonable to consider statins if concurrent lipid abnormalities need to be treated. This paper is accompanied by an excellent editorial by Dr. Francis Collins, who describes our journey in seeking a cure for this rare disease of Progeria. The fourth paper is by first author, Dr. Grisenti and corresponding author Dr. Tilley from Lewis Katz School of Medicine, Temple University in Philadelphia, and colleagues who aimed to better understand the role of leukocyte expressed beta-2 adrenergic receptors in regulating immune cell responses to acute cardiac injury. The authors achieved this aim by studying wild type mice who were irradiated, and then transplanted either with isoform specific beta adrenergic receptor knock out bone marrow, or wild type bone marrow. These chimeric mice, after full reconstitution then underwent myocardial infarction surgery. Results showed that immune cell specific beta-2 adrenergic receptor expression was essential to the repair process following myocardial infarction. In the absence of beta-2 adrenergic receptors, vascular cell adhesion molecule-1 expression was increased in leukocytes, inducing their splenic retention following injury, and leading to impaired scar formation, followed by rupture and death. Splenectomy partially restored the beta-2 adrenergic receptor deficient leukocyte infiltration into the heart, but gene therapy to rescue the leukocyte beta-2 adrenergic receptor expression completely restored all injury responses back to normality. This study is clinically important because it highlights a bit of a tension that we're facing. On the one had, beta adrenergic receptors are known to regulate cardiac function and remodeling following myocardial injury, by their effects through cardiomyocytes. That's why we use beta blockers to prevent, at first, cardiac remodeling. However, the current studies now indicate that inhibition or deletion of the immune cell expressed beta-2 adrenergic receptor causes leukocyte dysfunction, and impaired immunomodulatory responses to myocardial injury. These results may, therefore, have implications on the use of beta blockers around the time of acute myocardial injury, such as myocardial infarction, or perioperatively. This is really an area that needs further research and understanding. The fifth paper is by Dr. Herman, from the hospital of the University of Pennsylvania, and colleagues who report on the one year clinical outcomes of SAPIEN 3 transcatheter aortic valve replacement in high risk and inoperable patients with severe aortic stenosis. Now, as a refresher, in the initial partner trial of transcatheter aortic valve replacement for high risk and inoperable patients with severe symptomatic aortic stenosis, there was a demonstration of marked survival advantage compared to medical management ... But a high one year mortality of 24% in the high risk, and 31% in inoperable patients. More recently, the lower profile SAPIEN 3 prosthesis system has become available. Which has a balloon expandable cobalt chromium frame, with bovine pericardial leaflets, and an external fabric seal. The early 30 day outcomes of this system have been reported, and show a very low rate of adverse events. The current study now reports the one year survival, and showed that all cause survival was more than 85% for all patients, above 87% in the high risk, and above 82% in the inoperable subgroups. Furthermore, there was a high rate of transfemoral access at 84%, and a high all cause and cardiovascular one year survival in the high risk transfemoral subgroup of 89% and 93%, respectively. Between 30 and 365 days, the incidence of moderate perivalvular aortic regurgitation did not increase. There was no association between mild perivalvular leak and one year mortality. Although, a small increase in disabling stroke occurred. These results, which likely reflect device iteration and procedural evolution, support the use of Taver as a therapy to consider in high risk and inoperable patients with aortic stenosis. Those were the highlights from this week's issues, and now for our feature paper. We will be discussing the perspective paper entitled "Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Too Good to be True?". To discuss this, we have two very special guests. First, Dr. Sanjay Kaul, writer of this paper, and from Cedars-Sinai Medical Center. Second, Dr. Darren McGuire, deputy editor of circulation from UT Southwestern. Welcome, Sanjay and Darren. Dr. McGuire: Thanks, Carolyn. Dr. Kaul: Thank you, Carolyn. Dr. Lam: To start us off, I'd really love if Darren could please introduce this new content category of circulation. Frame of reference section, of which this is one of the papers, a perspective article. Dr. McGuire: Sure, so we envisioned, as we're evolving circulation to our new editorship, an opportunity for authors, luminaries in the field, to give us in a very encapsulated form, a laser focus perspective on a specific topic. These come in two flavors, the perspectives piece, which this is, is a little more evidence and scientific quantitatively based. Then we'll also have a section called on my mind, which is more of a free-flowing opinion editorial targeting possibly a contentious or controversial issue. These are going to be very short, and hopefully very entertaining, and kind of teasers for the readership of the Journal. Dr. Lam: Sanjay, you made it very personal, and I like that, too. Share with us how this idea came about. Dr. Kaul: Well, I was very impressed at the reception that the results of the EMPA-REG outcome trial received at the EAST meeting at Starcom last year. While I was witnessing the applause, I had polar reactions. On one hand, I thought that after nearly five decades of trials with checkered history, with regards to cardiovascular outcomes, here we have for the first time a trial demonstrating not only cardiovascular benefit, but a mortality benefit. I thought maybe it's time to take the trumpets out and sort of herald this holy grail, which we had failed to achieve. On the other hand, realizing that we had been fooled before many times by trials, yielding implausibly large treatments actually, that were never replicated at subsequent trials. I had a skeptical response to it, and sort of asked this question rather tongue-in-cheek, or maybe used as a rhetorical tool to address whether this mortality benefit was too good to be true. Dr. Lam: You know, you didn't just question it. You examined the data, and provided even more evidence. That's what I was impressed with in your paper. That table where you provided base factor, as well as a Bayesian analysis. Could you break that down for us, and explain what you found? Dr. Kaul: Yes, I was trying to sort of examine the strength of the evidence, in terms of the quantitative aspect. Yes, the effect size for the cardiovascular benefit was quite impressive. For the primary endpoint, which was a compositive cardiovascular, death, non-fatal MI, and non-fatal stroke, the p-value was not very robust. It was .04. The p-value tends to overestimate the strength of evidence. I utilized base factor, which basically is a metric that allows the two competing hypotheses to predict the data. Using the base factor, I was able to demonstrate that the alternative hypothesis was stronger than the null hypothesis by eight-fold. The p-value of .04 translated into a base factor of .13. Which is not strong evidence against the null hypothesis. It requires independent confirmation and subsequent trials. A p-value of .04, while meeting the superiority criteria, would not be sufficient enough to meet the FDA's requirement of substantial effectiveness. Substantial effectiveness just basically means that the FDA requires two trials, each with a p-value less than .05. In 1998, they modified their regulatory requirement, and accepted that one single trial would be sufficient, provided that there would be a persuasive p-value. Persuasive basically is defined as a p-value less than .001. The base factor allows us to sort of interpret the strength of the evidence, with respect to the primary composite endpoint was not strong enough to meet this requirement. With respect to cardiovascular mortality, as well as all cause mortality, which trumps all other endpoints, it was persuasive enough. Dr. Lam: What's your conclusion on that? Dr. Kaul: What is controversial about that was that in the three specified statistical plan, the so-called hierarchical testing strategy, the non-inferiority for three point MACE, followed by non-inferiority for four point MACE, and followed by superiority of three point MACE, and lastly, superiority of four point MACE. Because the p-value of four point MACE superiority was .08, one can argue purely from a statistical perspective that you stop your testing strategy, and any analysis beyond that would be deemed exploratory. Even though cardiovascular mortality and all cause mortality was prespecified, the purist would argue that since you failed superiority for four point MACE, you really can't proceed further. You can analyze, but it will be considered an exploratory analysis. I sort of wept and said that because Christopher Columbus had prespecified that he will be discovering the route to India, the fact that he stumbled upon America does not mean it doesn't exist because he had not prespecified it. I think all cause mortality is the most meaningful endpoint, and the least subjective measurement error. It meets the key attributes of regulatory decision making. Which it's prespecified, it's highly persuasive, therefore, it meets the replication criteria, and the p-value is so robust that even if you adjust for nearly 100 multiple comparisons, the p-value would still hold. It meets all the regulatory criteria for approval. Dr. McGuire: Sanjay, let me just chime in here. I think it's also important, not only were these prespecified, but it's important, I think, for readers of these diabetes programs to realize that hospitalization for heart failure ... Although it's not part of the primary outcome ... In virtually every one of these trials, it is prospectively collected, chartered to find, and essentially adjudicated by blind endpoint adjudicators. You know, death is death. Cardiovascular death in these programs are all adjudicated, as well. I think the prospective collection and central adjudication also adds legitimacy to the hospitalization for heart failure are above and beyond the analytic issues. Dr. Lam: Darren and Sanjay, I hear both of you kind of saying it does look like, even looking at it from different angles, the data do look strong. At the end of the day, Sanjay, you concluded that it does need another trial. Results do need to be replicated. That was your conclusion. I'd love to hear Darren's take on this. Dr. McGuire: I think what Sanjay is saying there, and I think what we all believe, was we would really love to see this observation with another member or members of the class. We're learning a lot in hindsight based on these observations, and people are exploring potential mechanistic underpinnings. We're learning a lot about the mechanisms of these medications, above and beyond their glucose uric effects. There's a lot of implication about renal physiology and hemodynamics, and altered myocardial metabolism. I think as Sanjay points out in the paper, some of this looks like a possible arrhythmic effect. We have a lot to learn about this mechanism of action, and whether or not this will be unique to impact gliflozin. It has been publicly announced, Boehringer Ingelheim is planning, they're in the planning phases for heart failure trials with empagliflozin to further explore this signal. I think they will address Sanjay's desire to have some replication in a different patient population. Still, we would love to see these extended into other patient populations. To both extend the use of the medications if they're found, but also provide further confirmation of the observations from EMPA-REG outcome. Dr. Kaul: Carolyn, let me also add, I used the title as a rhetorical tool, as I stated earlier. I do conclude that the mortality data is not likely to be spurious. In the back of my mind, I still have that 1% skepticism that I would like to eliminate, because the findings were totally unexpected, and unprecedented, as we discussed earlier. If all the pathways, including the mechanistic pathways are aligned, I would have substantial reassurance, beyond any reasonable doubt that the findings are true. That's why I'm asking for replication. Not necessarily by empagliflozin in other trials, but by another molecule within the same class. I think that would be sufficient. Dr. McGuire: Yeah, and I think it's really interesting to note there, is that I was involved in the early days of some of these drugs as they're being developed. When the other two members of this class went to the FDA, dapagliflozin and canagliflozin, they provided FDA's requirement and meta analysis from all of the phase 2B and 3 trials that had been completed to date. The meta analysis of the cardiovascular outcomes. Both dapagliflozin and canagliflozin had point estimates of cardiovascular death reduction of 30%, and 35%, respectively. When we saw those data, they were based on 25 to 40 total events. We chuckled, thinking this is spurious, from small events being analyzed. That there's no way they would prevent cardiovascular death. Sure enough, you know, you could almost superimpose those point estimate plots from the phase 2B-3 meta analysis, with the ultimate outcomes from EMPA-REG. There's some promising, although again, very statistically imprecise estimates that this may well be a class effect. As many of the listeners will know, there are ongoing cardiovascular outcomes trials for all of these medications. That will come some time in the next year or two. Dr. Lam: That's fantastic. Thank you both for sharing those perspectives. I mean, I learned so much. I really think, Sanjay, your paper achieved exactly what you had meant for it to achieve, and exactly what circulation was hoping to create the discussion, as well. Dr. McGuire: Thank you, Carolyn. Dr. Kaul: Thank you very much. Dr. Lam: You've been listening to Circulation on the Run. Thank you for listening. Don't forget to join us next week for more highlights and discussions.  

Clinician's Roundtable
U.S. Researchers Use Gene Editing to Remove HIV from 100% of Cells

Clinician's Roundtable

Play Episode Listen Later Apr 3, 2016


Host: Matt Birnholz, MD In the ongoing global campaign to prevent, treat, and cure HIV and AIDS, there have been countless therapeutic approaches targeting the HIV virus and everything it interacts with on the path to infection. But after decades of relentless infectivity claiming over 25 million lives, what if we could one day simply edit and delete the HIV virus right out of existence? Joining Dr. Matt Birnholz to discuss a novel research effort to leverage gene editing technology in the fight against HIV is Dr. Kamel Khalili, Professor and Chair of the Department of Neuroscience, Director of the Center for Neuro-virology, and Director of the Comprehensive Neuro-AIDS Center at the Lewis Katz School of Medicine at Temple University.